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Abstract 
Breast cancer is the second most common cancer among women in the United States. 
Sentinel lymph node biopsy for staging early breast c ncer in clinically node negative patients is 
supported by the American Society of Clinical Oncology due to a greater morbidity associated 
with axillary lymph node dissection. Quality of life benefits of sentinel lymph node biopsy 
compared to axillary lymph node dissection are inconsistent and many studies have used quality 
of life questionnaires alone.   
This descriptive correlational study was a primary nalysis of factors that predicted 
quality of life over two years based on a modified Health Related Quality of Life Model. The 
sample consisted of 185 women, ages 29 to 88 who had the new axillary reverse mapping 
surgical procedure following an axillary lymph node issection with sentinel lymph node biopsy 
or axillary lymph node dissection with or without sentinel lymph node biopsy. Descriptive 
analyses were conducted for occurrence of lymphedema and measures of physical function, 
general health perceptions, and health-related quality of life over two years.  Individual 
characteristics, relationships of biological factors, symptoms, and functional status to general 
health perception and health-related quality of life were evaluated through separate regression 
analyses conducted at three time points over two years.  Data were collected from the SF-36 and 
the axillary reverse mapping surgery form.  
Up to 31% of the variance in General Health Perception was explained by seven 
variables (age, body mass index, surgery, pain, lymphedema, physical functioning, and strength) 
with physical functioning and pain contributing the most.  As much as 37% of variance in mental 
component summary was explained by the same seven variables with physical functioning and 
pain contributing the most.  Only 19% of the variance for physical component summary was 
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explained by five variables (age, body mass index, surgery, lymphedema, and muscle strength) 
with body mass index and muscle strength contributing the most at two years.  Results provide 
information to help nurses formulate extended interventions and education for improving the 
perceptions and objective outcomes of women after undergoing axillary surgery for breast 
cancer.   
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Chapter 1 
Introduction  
Breast cancer is the second most common cancer among women in the United States and 
the second leading cause of death in women (American Cancer Society, 2013). Nearly one in 
eight (12%) women in the United States will develop invasive breast cancer during their lifetime. 
The American Cancer Society estimates approximately 232,340 new cases of invasive breast 
cancer will be diagnosed in the United States during 2013. The overall five-year survival is 89%, 
thus the prevalence of women who have undergone breast cancer is very high (National Cancer 
Institute, 2013).  
The clinical stage of breast cancer guides the surgical approach. American Joint 
Committee on Cancer uses the TNM (T-tumor, N-nodes, M-metastases) system for staging to 
determine breast cancer prognosis (Edge et al., 2010). The most common treatment for women 
with localized breast cancer is surgical excision and staging axillary lymph node evaluation with 
or without radiation therapy.  Based on treatment guideline, staging and prognostic factors, and 
the cancer care provider’s recommendations, a woman ay receive neoadjuvant chemotherapy 
or hormonal therapy administered to shrink a tumor before definitive removal of the tumor. 
Other treatment options are adjuvant chemotherapy, hormonal therapy, or monoclonal antibody 
therapy with the goal of eliminating or delaying disease recurrence (Bradley, 2007). Prognostic 
factors are important indicators at the time of surgery to evaluate the associated disease-free or 
overall survival if no systemic adjuvant therapy is administered (Cianfrocca & Goldstein, 2004).  
Lymph node metastasis is an important prognostic factor for breast cancer. Sixty-one percent of 
women with invasive breast cancer are estimated to have localized disease (Stage 0-IIB) with 
cancerous cells confined to the original cell layer or to breast lobes or ducts (with no metastatic 
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disease in the lymph nodes). Thirty-two percent have regional disease (i.e., spread to regional 
lymph nodes).  
Breast-conserving surgery is considered the standard procedure in early breast cancer 
generally followed by radiotherapy (Kaufmann, Morrow, von Minckwitz, & Harris, 2010). 
Initially after treatment, breast-conserving surgery is credited for providing a better body image 
than mastectomy (Arndt, Stegmaier, Ziegler, & Brenner, 2008). Mastectomy is the treatment of 
choice when there is high risk for local recurrence.  
In theory the sentinel lymph node(s) are the first d aining lymph nodes from the primary 
breast tumor (National Cancer Institute, 2013). Thesentinel lymph node (s) are removed and 
evaluated for cancer.  Selective sentinel lymph node biopsy (SLNB) is used in early breast 
cancer tumors with clinically and ultra sound negative involvement of the axilla to determine 
node spread.  When sentinel lymph node dissection is performed precise staging of the number 
of positive lymph nodes can be used to direct further reatment options (Glechner et al., 2013). 
Due to a greater morbidity associated with axillary lymph node dissection (ALND), SLNB for 
staging early breast cancer in clinically node-negative patients is supported by the American 
Society of Clinical Oncology (Lyman et al., 2005).  
National Comprehensive Cancer Network (NCCN, 2013) guidelines recommend no 
further surgery in women with negative SLNB and ALND for selected women with a positive 
SLNB. Avoiding ALND is desirable since complications of the procedure such as lymphedema, 
numbness, and stiffness in the arm can impact quality of life.  Lymphedema may occur early or 
late and frequently negatively affect function (Stout et al., 2012). Early intervention in patients 
with lymphedema may reduce the need for extensive rehabilitation and demonstrate a cost 
savings.  
                                                                             3 
 
Some studies have compared SLNB and ALND, showing that SLNB is associated with 
shorter hospital stay, quicker return to normal activity, and reduced rates of short- and long-term 
morbidities, such as infection, seroma, shoulder mobility impairment, neuropathy, and upper 
limb edema (Belmonte et al., 2012).  Quality of life benefits of SLNB compared to ALND are 
inconsistent. Quality of life studies have presented with problems such as absence of 
pretreatment assessment and reliable and valid quality of ife tools.  Goals in “Healthy People 
2020” include not only disease and disability relatd conditions, but also those related to quality 
of life.  According to Bredow, Peterson, and Sandau (2009) the term health-related quality of life 
is used to describe a more limited focus on areas of life most closely influenced by an 
individual’s health. As an interdisciplinary model health related quality of life includes 
measurement of variables that are traditionally important to nursing such as holistic 
consideration of an individual’s reactions to actual or potential illness.  
This proposed study is a primary analysis of the secondary outcomes not yet evaluated 
from the “Axillary Reverse Mapping: A Prospective Study in Women with Clinically Node 
Negative and Node Positive Breast Cancer” (Connor et al., 2013). Axillary reverse mapping 
(ARM) is a surgical procedure that uses blue dye to locate axillary arm lymphatics, such as the 
lymphatic channels or blue dye lymph nodes. 
The analyses of the secondary objectives were design d to evaluate occurrence of 
lymphedema and quality of life variables at set clini al follow up points and to compare quality 
of life measures between women with and without lymphedema. Quality of life and pain 
measured by (SF-36) were continuous and measured rep atedly over time (baseline, six months, 
one, two, and three years). Baseline demographics and creening information were recorded.  
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Background and Significance 
The status of the axillary nodes is still the most important prognostic factor for directing 
the impact of treatment.   Reported in the ACOSOG-Z0011 phase III randomized trial of ALND 
in women with stage I or IIA breast cancer and positive lymph nodes (Lucci et al., 2007), SLNB 
has gained preference over ALND for the staging of early breast cancer due to less morbidity and 
the questionable survival benefits of ALND.  These findings were part of a trend to move away 
from radical surgery for breast cancer. Rates of mastectomy declined in the 1980s after research 
showing survival rates following lumpectomy and radiation were comparable to those after a 
mastectomy (Fisher et al., 1989).  According to the Surveillance, Epidemiology, and End Results 
(SEER) Program of the National Cancer Institute (2013) approximately 89% of these women 
may be eligible for surgery involving resection of the axillary lymph nodes.    
Lymphedema is a recognized complication following axill ry staging for breast cancer. 
Sentinel Lymph Node Biopsy has reduced the risk with a reported 5-8% with SLNB alone 
compared to at least 13% after ALND (Ashikaga et al., 2010; Mansel et al., 2006).  
Lymphedema is an important consideration for nurses caring for breast cancer survivors due to 
its relatively high frequency and significant functional and quality of life implications for 
patients.  
Quality of Life  
Some studies have shown that breast cancer survivors with arm lymphedema experience 
a poorer quality of life and more psychological distre s than women without lymphedema 
(Pyszel, Malyszczak, Pyszel, Andrzejak, & Szuba, 2006; Ridner, 2005). Women who reported 
arm swelling also reported a significantly lower quality of life with multiple functional 
assessments (Paskett, Naughton, McCoy, Case, & Abbott, 2007). Shih et al. (2009) reported that 
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the psychosocial effects of breast cancer related to lymphedema to be as distressing as the 
primary diagnosis of breast cancer. Women with breast c ncer-related lymphedema have been 
reported to have a poorer quality of life, greater level of anxiety or depression, higher risk of 
chronic pain, fatigue, and added difficulty functioning socially and sexually compared to women 
with no lymphedema (Shih et al., 2009).   
Health and Illness Over Time 
According to Henly, Wyman, and Findorff (2011), change in health and illness over time 
is key to developing and evaluating interventions for individuals, families, and specific 
populations. The phrase health care trajectory is a concise and useful way to define change in 
health status over time. Understanding the path and c use of change in health over time allows 
anticipation of those at greatest risk for complicated trajectories and events, improves 
understanding of factors that impact change in healt  over time, and allows evaluation for 
outcome of interventions on the trajectory.  Increased understanding about the course and causes 
of change in health status over time creates the possibility of control by impacting the trajectory. 
With the use of random effects models for longitudinal data, advances in statistical 
modeling and computing have opened new avenues for designing longitudinal studies and 
analyzing results related to change (Laird & Ware, 1982; Muthen & Muthen, 2000). Valid health 
indicators should be used to measure change in values over time (Henly et al., 2011).  At present 
nursing research has been perceived as variable focused and for the most part lacks use of 
repeated measures or longitudinal designs needed to support a personalized science approach.  
A health trajectory science approach provides applicab e knowledge for improving 
nursing care and optimal outcomes, at the time of care and beyond for individual patients. 
Whether evaluating the course of a health experience or assessing the impact of an intervention 
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on health over time, theory about change, temporal design of a study, and a statistical model to 
define the influence of time on health is essential to underscore the individual experience (Henly 
et al., 2011).  .  
Theoretical Model 
 The framework for this study is based on a modification of the Wilson and Cleary’s 
(1995) original theoretical model of the Health-Relat d Quality of Life by Ferrans et al. (2005).   
Ferrans’ model (2005) as presented in Figure 1 consists of five domains of the original model: 
biological function, symptoms, functional status, general health perception, and overall health-
related quality of life. Overall Health-Related Quality of Life is described as subjective well-
being related to how happy or satisfied an individual is with life (Wilson & Cleary, 1995). The 
biological component is described as a continuum with the ultimate molecular, cellular, and 
organ function at one end and serious life threatening at the opposing end of the spectrum. The 
biological components in the current study that may pose threats to the biological process were 
body mass index, type of axillary surgery, and chemotherapy. The symptom component is 
described as the individual’s perception of abnormal physical and emotional states. Symptoms 
assessed included pain (subjective) and lymphedema (objective assessment). Functioning is 
defined by physical, psychological social, and role function. Physical functioning was measured 
by the SF-36 scores, muscle strength, and shoulder flexibility (recorded on the axillary reverse 
mapping form).  General health perceptions signify a subjective scoring that includes all 
preceding health concepts. Overall quality of life is denoted as subjective well-being that is 
referring to how happy or satisfied an individual is with life as a whole.   Each domain is related 
to the others and reciprocal links likely exist.  Explicit definitions were provided to better explain 
individual characteristics (i.e., intrapersonal factors) and environmental characteristics (i.e., 
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interpersonal factors, institutional factors, community factors, and public policy).  Ferrans et al. 
(2005) model connects specific clinical factors to Health-Related Quality of Life. In general the 
Ferrans et al. model has been described as complex due to the multiple relationships.  
Following the development of a substruction model (See Appendix A), a modification of 
the Health-Related Quality of Life model (Ferrans et al, 2005) was used as the foundation of this 
study to identify factors affecting the health relat d quality of life in women undergoing axillary 
surgery after the diagnosis of breast cancer. The variables included in this study are illustrated in 
Figure 1.  The model was revised in an effort to simpl fy and clarify the critical elements of 
health related quality of life for women post axillary surgery and to establish causal relationships 
among them.   The solid lines indicate the research questions to be tested in this study.  The 
dotted lines indicate potential future use of the model.  
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Figure 1. Modified Model of Health-Related Quality of Life (HRQOL)  
 
 
 
 
 
Figure 1.  Adopted from “Conceptual Model of Health-Related Quality of Life,” by Ferrans, C.  
E., Zerwic, J. J., Wilbur, J. E., & Larson, J. L, 2005, Journal of  Nursing Scholarship, 37, p. 338.  
  
 The quality of life factor domains in early breast cancer patients post SLNB with or 
without ALND may include biological function, symptoms, functional status, general health 
perceptions, and overall quality of life. Exploring quality of life domains most relevant to breast 
cancer survivors’ post-axillary lymph node surgery is critical in determining areas of intervention 
to help improve physical and mental components for health-related quality of life for two years 
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post-surgery.  Demographics, muscle strength, shoulder flexibility, and the SF-36 were sources 
used to measure the various domains.  The modified health-related quality of life proposed in this 
study was designed to examine the relationship of lymphedema (yes/no) and treatment (SLNB or 
ALND with or without SLNB) and (a) characteristic of the individual, (b) biological factors, (c) 
symptoms, and (d) functional status, to general healt  perceptions and overall health-related 
quality of life of breast cancer survivors who received a post axillary reverse mapping procedure 
with SLNB or ALND with or without SLNB. In the studied breast cancer sample individual 
characteristics biological function, symptoms, and physical function were evaluated as 
simultaneous and independent predictors for general h alth perception and overall quality of life.         
Statement of Problem 
Approximately one-third of breast cancer survivors in general, the majority being African 
American women, presents with regional disease and positive lymph nodes; consequently, they 
require complete ALND (Sagen et al., 2009). The relationship of physiological indicators 
associated with breast post-axillary breast cancer surgery and measures of quality of life are not 
well characterized.  Belmonte et al. (2012) reported that many studies evaluating quality of life 
have used quality of life questionnaires alone.  A meta-analysis of six studies in more than 
11,500 women reported a higher risk for harm with ALND than SLNB. Literature on relevant 
health outcomes over time is missing.  According to Belmonth et al. (2012) controversy remains 
regarding quality of life benefits for SLNB compared to ALND in breast cancer patients.  
Estimates of the incidence and prevalance of lymphedema vary greatly (Poage, Singer, Armer, 
Poundall, & Shellabarger, 2008). Nurses and health c re providers can use information from this 
study to provide tailored intervention and education  support women post breast axillary lymph 
node surgery throughout their health care trajectory.  
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Purpose of Study 
The purpose of the study was to identify components (i.e., individual characteristic [age], 
biological factors [body mass index, SLNB or ALND with or without SLNB, chemotherapy], 
symptoms [pain and lymphedema versus no lymphedema], and functional status [muscle 
strength, shoulder flexibility, and SF-36 physical function scale score] within the modified 
Health-Related Quality of Life model (Ferrans et al., 2005) that may predict general health 
perspective (SF-36 general health perception score) and overall quality of life (SF-36 physical 
and mental scores) of women with early breast cancer over time during the first 2 years after 
surgery (See Table 1, p. 38). The objective is to es ablish risk groups among women undergoing 
the newer axillary reverse mapping procedure for establi hing those who may benefit from 
additional intervention.  
Research Questions. The following research questions were explored:  
1. What are the levels of pain, physical function, general health perceptions and health 
related quality of life over time (baseline, six months, one year, and two years) for 
women after axillary reverse mapping procedure?  
2. Are there differences in physical function for women who had SLNB only or ALND with 
or without SLNB and women who did or did not receive chemotherapy measured over 
time (baseline, six months, one year, and two years)? 
3. What is the occurrence of lymphedema (Yes/No) with measures of physical function, 
general health perception, and health-related quality of life over time (baseline, six 
months, one year, and two years)? 
4. Controlling for an individual characteristic (age) what are the relationships of biological 
factors (body mass index, SLNB or ALND with or without SLNB), symptoms (pain), and 
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functional status (SF-36 function score, muscle strngth, flexibility) to general health 
perception and health-related quality of life  at three separate time points (six months, one 
year, and two -years).  
Assumptions  
Subjects’ self-reported quality of life reflected their actual quality of life. Understanding 
relationships between these components will support the future design of optimally effective 
clinical interventions.  
Definitions of Terms 
The following are terms defined for the present study:  
Adjuvant Therapy  
Adjuvant therapy as a treatment for breast cancer is administered after primary therapy to 
improve the chance of long term survival (National C ncer Institute, 2013).   Primary therapy for 
breast cancer generally includes surgery such as mastectomy or lumpectomy.  Oncologist 
provides adjuvant therapy to destroy any cancer cells that may have spread, even if undetected 
by imaging or laboratory tests. Adjuvant therapy for breast cancer may include chemotherapy, 
hormonal therapy, targeted drug therapy, and/or radiation therapy.  
Axillary Lymph Node Dissection    
 An axillary lymph node dissection is a surgical procedure to remove lymph nodes from 
the axillary region.  
Axillary Reverse Mapping (ARM) 
 Axillary reverse mapping is an intraoperative technique designed to establish the 
lymphatic drainage in the upper extremity during a sentinel lymph node biopsy or axillary lymph 
node dissection. This procedure involves injection of dye to identify lymphatic drainage from the 
arm to enable preservation of lymphatic vessels. The technique had been examined for the 
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prevention of upper extremity lymphedema in patients undergoing surgery for breast cancer 
(Boneti et al., 2012).  
Breast Conserving Surgery 
Breast-conserving surgery is performed to remove the breast cancer without removal of 
the entire breast. Examples of breast conserving surgery are lumpectomy (removal of the lump), 
quadrantectomy (removal of one quarter, or quadrant of the breast tissue), and segmental 
mastectomy (the cancer as well as some of the breast tissue and around the tumor and lining of 
the chest muscle beneath the tumor).  
Clinical Staging 
 Staging is a standardized way for physicians to evaluate findings related to how far the 
cancer has spread. The most common system to depict staging of breast cancer is the American 
Joint Committee on Cancer TNM (tumor, nodes, and metastasis) system.  Breast cancer staging 
is determined by the results of physical exam, biopsy, and imaging tests (referred to as clinical 
staging), or on the findings of these tests in combination with the findings from surgery 
(pathological staging) (Edge et al., 2010). 
Contralateral Lymph Node 
 Lymph node located on the opposite side of the body as the breast cancer (National 
Cancer Institute, 2013).  
Crossover 
A crossover event consists of identification of one r more lymph nodes that are both 
focally radioactive after Tc99m injection and noticeably stained blue after ipsilateral arm 
injection with Lymphazurin (Connor et al., 2011).   
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Early Breast Cancer 
The term early stage breast cancer is used in referenc  to cancer that has not spread 
beyond the breast or axillary lymph nodes. It generally includes ductal carcinoma in situ and 
stages I, IIA, IIB, and stage IIIA breast cancers (National Cancer Institute, 2013; National 
Comprehensive Cancer Network, 2013). 
Ipsilateral Lymph Node 
Lymph node located on the same side of the body as the breast cancer (National Cancer 
Institute, 2013).  
Lymphedema  
 Lymphedema is a condition that can occur when axillary ymphs are removed during 
breast cancer surgery (National Cancer Institute, 2013).  Lymphedema is defined by Connor et 
al. (2011) as a change in arm circumference of greate  than 2 cm when compared to the 
contralateral arm and with the baseline measurement.  
Modified Radical Mastectomy 
 The operation involves removal of the entire breast, including skin, areola and nipple, as 
well as most of the axillary lymph nodes, sparing the muscle (Cotlar, Dubose, & Rose, 2003). 
Neoadjuvant Therapy 
Primary therapy for breast cancer generally includes surgery such as mastectomy or 
lumpectomy (National Cancer Institute, 2013).   Neoadjuvant therapy is treatment administered 
before primary therapy.  
Sentinel Lymph Node  
The sentinel lymph node is the first lymph node to where cancer is probable to spread 
from the breast tumor (National Cancer Institute, 2013). There may be more than one sentinel 
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lymph node.  When cancer metastasizes it may appear first in the sentinel node prior to spreading 
to other lymph nodes.  
Lymph node status 
Lymph node status determines whether or not the lymph nodes in the underarm (axillary 
nodes) are cancerous.  Lymph node-negative indicates the lymph nodes do not contain cancer 
and lymph-node positive indicates they lymph nodes do contain cancer.  A physical exam (also 
referred to as clinical exam) can give an initial estimate of lymph node status (Komen, 2013). 
Summary 
A large portion of women with a diagnosis of breast cancer undergo axillary staging with 
approximately 5% developing lymphedema with SLNB and 20 % ALND. Avoiding ALND is 
favorable due to complications such as lymphedema, numbness, and stiffness in the arm 
impacting quality of life. Quality of life benefits of SLNB compared to ALND are inconsistent 
with many studies having used quality of life questionnaires alone. Axillary reverse mapping is 
an emerging surgical procedure using blue dye to locate axillary arm lymphatics.  A modified 
conceptual model was developed from the health related quality of life model to determine 
predictors of quality of life in breast cancer survivors undergoing axillary reverse mapping 
procedure.  
This primary analysis of the secondary outcomes was proposed to address the lack of 
literature on quality of life measures over time in patients who have or have not had this new 
surgical procedure to reduce the possibility of lymphedema and other morbidities occurring. The 
descriptive correlational design provides a foundation o describe variables over a two year 
period and the relationship among the variables. Relationships of biological factors, symptoms, 
and functional status to general health perception and health-related quality of life will be 
evaluated through regression analysis at 3 time points ver two years.  Findings from this study 
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will contribute to knowledge that can lead to future nursing interventions to improve the quality 
of life of breast cancer survivors with and without lymphedema.  
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Chapter 2 
Review of Literature 
The purpose of this literature review was first to give an overview of health related 
quality of life models and the increased use of such models as a framework for the analysis of 
clinical variables and quality of life.  The second and primary portion of the review addresses 
research that explores the elements of health-related quality of life and their determinants.  The 
concepts presented are biological factors (body mass index, SLNB or ALND with or without 
SLNB, and chemotherapy,), symptoms (pain and lymphedema), functional status (SF-36 physical 
function scale score, muscle strength, and shoulder flexibility) , general health perceptions, and 
overall quality of life in women post-axillary lymph node surgery.  The review examined factors 
that may influence the five main components such as an individual characteristic (age).  Finally, 
research studies or theoretical information related to etermination of quality of life are 
presented.   
The information gathered from the literature review ncludes both published and 
unpublished books, journals, periodicals, and webpages from 1980 through November, 2013. 
The search was conducted using PubMed and Cumulative Index of Nursing and Allied Health.  
An internet search was completed using the Google Scholar search engine at the World Wide 
Website.  After articles were reviewed, a secondary review of references and bibliographies was 
conducted.  
History of Quality of Care in Oncology 
 Nearly 30 years have passed since the founding of the National Coalition for Cancer 
Survivorship (Hoffman, 2004). When the National Coalition for Cancer Survivorship’s founding 
members met in 1986 they rejected the historic definition of a cancer survivor as an individual 
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who had remained disease free for five years (Rowland, 2006). Since then they have been 
instrumental in embracing the right for individuals to label themselves as cancer survivors from 
the point of diagnosis through the remainder of their lif , irrespective of whether death was 
eventually related to cancer. The intent for adopting he new language was to foster a change in 
the provider-patient communication in relation to can er.  
 At the onset it was recognized that the bulk of patients diagnosed with cancer were living 
longer and discussion about long-term survival needed to be part of the early dialogue. The 
coalition acknowledged there were varying needs experienced by survivors across the cancer 
journey and recovery, articulately described by Fitzhugh Mullan (1985) as “seasons of survival”. 
The notion and advocacy by the National Coalition fr Cancer Survivorship resulted in the 
concept of survivorship that is described as the period of health and well-being experienced by 
survivors after active cancer treatment (and possibly before a recurrence or a diagnosis of a new 
malignancy); it is considered a specific phase of the cancer control continuum being integrated 
into the oncology language. 
 Nursing’s interest in quality of life can be traced back to Florence Nightingale’s 
involvement with the British Military. Her contributions provided examples of how nurses could 
promote individual quality of life (Bredow, Peterson, & Sandau, 2009). The Oncology Nursing 
Society’s Research Priority Survey in 1991, found quality of life to be consistently ranked as a 
research priority (Mooney, Ferrell, Nail, Benedict, & Haberman, 1991).   
 The Office of Cancer Survivorship at the National Cncer Institute was established in 
1996. The Office of Cancer Survivorship was a direct sult of compelling and articulate 
consumer advocacy for more consideration to the unique and inadequately understood needs of 
the expanding population of cancer survivors. The dir ctive of the Office of Cancer Survivorship 
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is to improve duration and quality of life of all individuals diagnosed with cancer (National 
Cancer Institute, 2013). The American Society of Clinical Oncology introduced a “Patient 
Survivor Care” track to its annual meeting in 2006 with the goal of recognizing the growing 
number of cancer survivors and the key role of oncologists in meeting their health care needs. 
Work on survivorship issues at the Institute of Medicine is ongoing with an in-depth evaluation 
of psychosocial care provided for cancer survivors. The study follows a 2004 report, Meeting the 
Psychosocial Needs of Women with Breast Cancer (H witt, Herdman, & Holland, 2004).  
 Post axillary-surgery quality of life has not been studied empirically to a large degree. 
The following literature review will examine references related to quality of life in breast cancer 
(specific to axillary lymph node surgery when available) in the five domains along with age as an 
individual characteristic that may influence the five domains.  
Health Related Quality of Life Model 
Many health-related quality of life models have been applied between several health and 
illness conditions, across lifespan, and among indiv duals, families, and groups. A systematic 
review of health-related quality of life models by Bakas et al. (2012) identified that out of 100 
articles published between 1999 and 2010 the most frequently used health related quality of life  
models were: Wilson and Cleary (1995a), Ferrans et al. (2005), or the World Health 
Organization (2007). Forty-six of the 100 articles were quantitative research (mainly descriptive 
studies), 16 were qualitative research, and the othrs were mixed methods, instrument 
development, literature review, model revision, and consensus paper.  Three of the 100 articles 
used Ferrans health-related quality of life as guidance (two related to traumatic brain injury and 
one related to instrument development for maternal post-partum quality of life measures).  One 
article by Klassen, Pusic, Scott, Klok, and Cano (2009) described the impact of breast conditions 
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and surgery (breast reduction, augmentation, or reconstruction) to develop a quality of life 
framework specific to breast surgery. Due to the broad variety in disease states, health-related 
quality of life domains and specific characteristic could not be sufficiently analyzed.  
 Ferrans et al. (2005) health-related quality of life model, a revision of Wilson and Cleary 
(1995) model, was noted as having the greatest potential to guide future research and practice. In 
addition, authors recommend Ferrans and colleagues’ model because they added individual and 
environmental characteristics to explain health-related quality of life. The WHO International 
Classification of Functioning and, Disability, and Health was seen as a less favorable option 
because it is viewed more as a model of mapping and clarification rather than a guide for 
hypothesis generation (Bakas et al., 2012).  
 Ferrens, Zerwic, Wilbur, and Larson (2005) revised Wilson and Cleary’s (1995) model. 
The revised model maintained the five original domains. Changes included making explicit the 
definitions for individual and environmental characteristics, simplifying the portrayal of the 
model by removing non-medical factors and descriptions on the arrows illustrating the 
relationships in Figure 1. Furthermore, they contributed additional theoretical language regarding 
the basic concepts in the model and provided examples of instruments to enrich measurement 
such as the SF-36 (Bakas et al., 2012).   
 The model by Ferrans et al. (2005) can be considered parsimonious because it has seven 
main concepts to explain the construct of health-related quality of life; on the other hand it is 
complex due to the multiple relationships. To evaluate the relationships of biological factors 
(body mass index, SLNB or ALND with or without SLNB), symptoms (pain and lymphedema) 
and functional status (SF-36 function score, muscle trength, and flexibility) to general health 
perception and health-related quality of life a revision to Ferrans et al. (2005) were proposed 
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(See Figure 1).  Characteristics of the individual were retained in the proposed model with an 
arrow from the concept to biological function, symptoms, and physical function.  Environmental 
characteristics were  not available to test for this study. Biological function, symptoms, and 
physical function have the potential for a reciprocal relationship with a linear or reciprocal 
relationship to general health and overall quality of life.   
Characteristics of the Individual  
 As described by Ferrans et al, (2005), epidemiologcal evidence suggests a connection 
between individual characteristics and biological function through detecting attributes or 
behaviors that increase or decrease the odds of developing a given health risk or problem. 
Examples of biological factors are: body mass index, skin color, or family history related to 
genetic risk factors.  Demographic factors that may be associated with the incidence of illness are 
sex, age, marital status, and ethnicity.  While some personal factors are unchangeable, they may 
be useful in targeting health intervention.  Developmental status, an individual characteristic, can 
be important to contemplate when explaining health be avior and its impact on biological 
function. Interventions planned to change or modify behavior demand consideration of an 
individual’s developmental status.  For example, women with small children might be receptive 
to an at-home exercise program post-breast surgery to reap the rehabilitation benefits. Last, 
cognitive appraisal, affective response, and motivation are considered dynamic psychological 
factors that have the ability to influence one another.  
 Age. Increasing age is a risk factor for breast cancer (National Cancer Institute, 2013).  In 
a study of women (n=93) who were evaluated for quality of life impact of SLNB versus ALND 
had an average age of 59.2 years (SD= 8.6) (Belmonte et al., 2012).   A publication by Yi et al. 
(2010) identified 26,986 patients with disease positive lymph nodes, of which 4,425 experienced 
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SLNB only and 22,561 experienced SLNB with ALND. Women were significantly more likely 
to undergo SLNB alone if they were older (median age = 59 years) or if the cancer was low 
grade and estrogen receptor positive.  Boneti et al. (2009) studied a sample of 220 women (M = 
60.3 years; SD= 11.3) undergoing axillary reverse mapping to identify and preserve lymphatic 
draining the arm and the impact on lymphedema.  This was consistent with the age (M= 60 
years) reported in the initial analysis by Connor et al. (2013).  
 Research supports that women of various ages diagnosed with breast cancer have 
different concerns and needs (Loerzel, McNees, Powel, Su, & Meneses, 2008).  Nonetheless, 
literature on the needs of women with breast cancer who are 65 years or older in the first year of 
survivorship is scarce; consequently, healthcare providers have little knowledge of the 
similarities and differences in older survivors and their younger equivalents.  From a study of 
older women with early-stage breast cancer, Loerzel et a . (2008) reported positive quality of life 
in the first year of survivorship, but overall quality of life declined overtime.  Exclusion criteria 
or absence of participation of older women in clinial trials has led to knowledge scarcity of 
quality of life among older women with breast cancer.  
 In a study of 266 women evaluating the time-course of lymphedema and potential risk 
factors for progression of lymphedema after breast conservation treatment, Bar Ad et al. (2012) 
reported age greater than 65 years of age at the time of breast cancer treatment was significantly 
related to higher rate of arm lymphedema when compared to women 65 years of age or younger.  
Biological Function 
 Biological function (formerly biological and physiological variables) is a comprehensive 
view that encompasses molecular, cellular, and the entire organ level processes (Ferrans et al., 
2005). Biological functions can be assessed through s c  factors as laboratory tests, physical 
                                                                             22 
 
assessment, and medical diagnosis. Shifts in biological function directly or indirectly influence 
all components of fitness, including symptoms, functional status, perceptions of health, and 
overall quality of life. Enhancing biological function is an essential part of holistic care. The 
interaction of individual and environmental characteristics likewise impacts biological function.  
For example, psychological characteristics, knowledge, and attitudes impact decisions 
individuals make about lifestyles eventually affecting biological function.  Exposure to 
pathogens in the environment may increase the in risk of infection to a wound.  
 Body Mass Index.  In a study of 133 women undergoing breast conserving surgery 
(SLNB with or without ALND), obesity was found to be a risk factor for developing 
postoperative lymphedema in breast cancer in patients (Helyer, Varnic, Le, Leong, & McCready, 
2010).  Women with a body mass index greater than 30 (obese) had twice the risk of developing 
lymphedema compared to those with a body mass index of l ss than 25.  A small clinical trial 
(N=21) examining weight reduction as a treatment for breast cancer-related lymphedema found 
weight loss may significantly decrease lymphedema (Shaw, Mortimer, & Judd, 2007).  A 
prospective study tracked 138 breast cancer survivors for 30 months post diagnosis (Ridner, 
Dietrich, Stewart, & Armer, 2011).  Women with a body mass index of 30 or greater at the time 
of diagnosis were 3.6 times more likely to develop lymphedema. Weight gain after diagnosis was 
not related to lymphedema.   There is a lack of research to evaluate whether weight loss among 
women at risk for developing lymphedema would decrease risk (National Cancer Institute, 
2013).  
Empirical evidence suggests that upper-body exercise does not increase risk for 
lymphedema.  Sagen, Karesen, and Risberg (2009) evaluated physical activity for the affected 
limb and arm lymphedema after breast cancer surgery. The authors concluded that women 
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undergoing breast cancer surgery with ALND should be encouraged to maintain physical activity 
in their daily lives without limitations or concern for arm lymphedema.  
 The association between body mass index and lymphedema is poorly understood.  The 
researchers suggest that it could be a product of a heavier limb with extra subcutaneous tissue, 
adipose, and skin serving as a reservoir for lymphatic fluid or possibly due to the surgery being 
more extensive as a result of the existence of adipose tissue and hence more trauma to the 
lymphatics (Ozaslan & Kuru, 2004; Werner et al., 199 ) .   
 Helyer et al. (2010) recognized research is limited regarding determinants of lymphatic 
flow and more studies on lymphatic drainage and impedance must be conducted to sufficiently 
explore the pathogenesis of lymphedema in the obese.  Several researchers (Boneti et al., 2009; 
Thompson et al., 2007) have reported results of their experience with axillary reverse mapping. 
The focus of these studies has been to evaluate the ability of axillary reverse mapping to identify 
and preserve lymphatics draining the arm and its impact on lymphedema.  There was no 
literature identified on determinants such as body mass index associated with lymphedema in 
axillary reverse mapping.   
  Chemotherapy.  Evidence supports that women undergoing treatment of breast cancer 
may experience a number of symptoms that reduce their functional status and quality of life.  
Hofso, Miaskowski, Bjordal, Cooper, and Rustoen (2012) evaluated for differences in the 
symptom experience and quality of life of women with breast cancer who did and did not receive 
chemotherapy prior to radiation therapy.  The five symptoms with highest association to poorer 
quality of life were lack of energy, worrying, difficulty sleeping, feeling drowsy, sweats, and 
pain. Women who received chemotherapy prior to radiation experienced two-fold the number of 
symptoms as women who did not receive chemotherapy. Poorer functional status, a greater 
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comorbidity score, and prior chemotherapy were all determinants of a greater number of 
symptoms. In a study of 772 patients with breast cancer, who had a primary surgery with ALND, 
667 (88%) received adjuvant chemotherapy (Kim et al., 2013). Of those women receiving 
chemotherapy, 18% experienced lymphedema compared to only 2% in the group not receiving 
chemotherapy.  
 Lymph Node Status.   Kim et al. (2013) also found lymphedema rates in women with 
≤10 axillary dissected lymph nodes was 6% and those with > 10 was 27% (p < .001).  A case-
control study of 94 women to evaluate predictors of lymphedema after breast cancer surgery 
found no significant difference between negative versus positive lymph node status, but they did 
find the number of positive lymph nodes was significantly greater in women with lymphedema 
when compared to controls (p =0.009) (Swenson,  Nissen,  Leach,  & Post-White, 2009).  
Liljegren and Holmberg (1997) reported  in a study of 381 women undergoing a segmental 
mastectomy and ALND, that those with ten or more lymph nodes removed were less likely than 
women with fewer lymph nodes removed  to develop lymphedema during the first year (53% vs. 
33%) and during the next two years (33% vs. 20%).  
 Axillary Surgery. Lymphedema alone is known as a complication after axillary staging 
for breast cancer. SLNB has reduced but not eliminated the chance of this complication. The 
reported risk of lymphedema ranges from 5-8 % with SLNB alone and a minimum of 13 % after 
ALND (Ashikaga et al., 2010; Mansel et al., 2006). Axillary reverse lymph is an intraoperative 
technique developed to establish the lymphatic drainage in the upper limb during a sentinel 
lymph node biopsy or axillary lymph node dissection (Conner et al., 2013). The procedure 
involves injection of dye to identify lymphatic drain ge from the arm to facility preservation of 
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lymphatic vessels.   This technique was evaluated in all patients in this study for the prevention 
of upper limb lymphedema in women undergoing surgery for breast cancer.   
Symptoms 
 Instruments used to measure symptoms may be categoriz d as global, condition-specific 
measures, and symptom-specific measures. Global measures are broad and capture various 
symptoms where condition-specific measures are focused on symptoms related to certain 
conditions. Symptom-specific measures pertain to a particular symptom such as pain measured 
by a visual analog pain scale from 0-10 (Wong-Baker Faces Foundation, 1983).  The dimension 
of symptoms measured are comprised of frequency, intensity, and distress in addition to quality, 
cause, treatment, consequences, location, and timing. An individual’s experience, evaluation, and 
interpretation of symptoms are influenced by multifaceted interactions with both individual 
factors (i.e., knowledge and personal characteristics) and environmental factors (i.e., interactions 
with a rehabilitation specialist).  
 Pain. One study of 49 patients evaluated pain at 3.0 months and 3.4 years after recovery 
of upper limb function following axillary lymph node dissection (Devoogdt et al., 2011). The 
authors reported that women had equal levels of pain and discomfort, associated with arm 
movement, 3.0 months and 3.4 years after surgery with a median visual analog scale score of 2.0. 
At three months after surgery, 96% of women expressed pain and discomfort. This number 
decreased by 17% (p < 0.05) to 79% at 3.4 years after surgery. Seventy-nine percent of women 
reported a visual analog score ranging between one and seven.  Fifty-six percent of women 
reported a visual analog score between one and four (mild pain) and 23% had a visual analog 
score between five and seven (moderate pain). There was no report of severe pain.  A positive 
correlation was found between the visual analog scale score at 3.0 months and 3.4 years follow 
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up.  There was no significant difference in the incidence of pain between the mastectomy (33%) 
and breast-conserving surgery (67%) group.  
 According to a study by Swenson et al. (2002) breast c ncer patients undergoing SLNB 
(n=169) had less pain at one and six months post-surgery compared to those who had an ALND 
(n=78).   Additionally, researchers (Schrenk, Rieger, Shamiyeh, & Wayand, 2000) reported 
significantly higher rates of pain in patients after ALND compared to SNLB. Currently there is 
insufficient research data regarding incidence of post-axillary reverse mapping pain.  
 Arm Circumference/Lymphedema. According to Erickson, Pearson, Ganz, Adams, and 
Kahn (2001), lymphedema varies from 0% to 56%, and up to half of breast cancer survivors 
reported symptoms consistent with lymphedema with or without a clinical diagnosis (Ahmed, 
Prizment, Lazovich, Schmitz, & Folsom, 2008).  Lymphedema is clinically described as a 
swelling (at minimum 200 mL by volume or 2 cm by circumference measurement) of the 
affected arm compared to the non-affected arm. There are a number of methods in the literature 
for assessing limb volume; however, lack of standardiz tions makes it challenging for 
professionals to evaluate the at-risk extremity (Ridner, Montgomery, Hepworth, Stewart, & 
Armer, 2007).  Possibilities for limb volume are water displacement, tape measure, infrared 
scanning, and bioelectrical impedance measures. The most common method for diagnosis of 
lymphedema is circumferential upper-extremity measurement using specific anatomical land 
marks (National Cancer Institute, 2013).    
Lymphedema is identified as an independent predictor of decreased quality of life, even 
when other predictive factors such as socioeconomic status, decreased range of motion, age and 
obesity are adjusted for or used as covariates ( Petrek, 2004). The presentation of lymphedema 
may be insidious. Lymphedema may be abruptly triggeed by local inflammation from causes 
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such as infection or limb injury and is characterizd by non-pitting swelling of the arm often 
involving digits. Lymphedema also may progress to recu rent skin infections (Bicego et al., 
2006). Symptoms accompanying lymphedema include: heavin ss or fullness related to the 
weight of the arm, a tight sensation of the skin, or limited flexibility of the affected joint 
(National Cancer Institute, 2013). Activities of daily living, hobbies, and the capability to 
perform previous tasks, may be affected. Breast cancer survivors with arm lymphedema have 
been found to have more disability, poorer quality of life, and a greater psychological distress 
than women without lymphedema (Pyszel, Malyszczak, Pyszel, Andrzejak, & Szuba, 2006; 
Ridner, 2005).  
Lymphedema has been reported to develop within daysto 30 years after treatment of 
breast cancer (Shaw, Mortimer, & Judd, 2007).  One study found that 80% of women develop 
onset within three years of surgery while the rest experience edema at a rate of 1% per year 
(Petrek, Senie, Peters, & Rosen, 2001). The incidene of arm lymphedema can span from 8% to 
56% at two years post-surgery (Petrek et al., 2001).  Data are inconsistent on the incidence and 
prevalence of lymphedema after breast cancer that may be due to the differences in patient 
characteristics.  
 In the Iowa Women’s Health Study of 1,287 breast cncer survivors, 104 reported 
lymphedema and 475 reported arm symptoms (Ahmed et al., 2008).  The authors reported 
women diagnosed with lymphedema or arm symptoms without lymphedema experienced lower 
physical and mental scores on the health-related quality of life.   
Functional Status 
        People typically do not function at full capacity on a daily basis (Ferrans et al., 2005). 
Even those with high capacity might only use a portion of their capacity on a day-to-day basis.  
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When health problems cause a decline in functional capacity, it might be necessary for an 
individual to use a higher percentage of capacity or to reduce daily activities.  
 Measures of functional capacity have been broadly reported in the scientific literature 
with several established measures available.  For instance, testing muscle strength indicates 
functional capacity for strength.  Scales from the SF-36 Health Survey (Ware & Sherbourne, 
1992a) have been used often to measure physical and social function. The SF-36 is a generic tool 
that can be administered to healthy individuals or th se with a chronic disease. The dimensions 
of capacity utilization and functional reserve are viewed as clinically meaningful and typically 
measured subjectively. 
 SP-36 Physical Functioning Score. Segal et al. (2001) evaluated the impact of exercis 
on physical function using the SF-36 physical functioning scale in women with stage I and II 
breast cancer during adjuvant therapy. The physical functioning scale consists of ten items that 
evaluate several aspects of physical functioning and span severe and minor limitations.  
Researchers reported a significant (p=0.04)  decrease in physical function in the control g up by 
4.1 points, and an increase by 5.7 and 2.2 points in the self-directed and supervised exercise 
groups, respectively (Segal et al., 2001).  
 Muscle Strength and Flexibility. Rietman et al. (2004) conducted a study to evaluate 
impairments, disabilities and health-related quality of life in 52 women after a modified radical 
mastectomy or segmental mastectomy with ALND, and to analyze the association between 
treatment modalities, disabilities, and health-related quality of life.  The mean follow up was 2.7 
years.  Active shoulder range of motion, grip strength, arm volume, and pain were used to 
measure impairments.  The Shoulder Disability Questionnaire was used to assess disabilities and 
the RAND-36 item Health Survey was used to measure health-related quality of life. The most 
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frequent impairments found were pain (60%) and reduction of grip strength (40%).  The 
occurrence of impaired range of motion (>20°) was 9 to 16% and of edema was 15%.  Mean 
scores on the RAND-36 contrasted significantly (p<.05) on scores of physical functioning, 
vitality, and health perception to a female control group.  Chemotherapy and radiation were 
determinants for impaired ROM.   Pain and restricted range of motion explained 61% and 12%, 
respectively, of the disability.  Pain, grip strength, and arm volume were significant (p<.05) 
predictors of health-related quality of life.  
 Velloso, Barra, and Dias (2011) explored possible impairments and functional 
performance of the upper extremity on activities of daily living and health-related quality of life 
among breast cancer survivors treated through SLNB and investigated the association between 
variables.  Results showed a 75% prevalence of sympto s impacting the affected upper 
extremity (pain or discomfort in arm or shoulder) or breast with the severity rated as mild.  Only 
4.4% of the 54 women evaluated experienced lymphedema and no range of motion restriction 
was detected. Researchers found minimal functional limitation of the upper arm and concluded 
that SLNB preserves upper extremity function with li tle impact on quality of life.  
General Health Perceptions 
Two defining characteristics of general health perceptions are: (a) they integrate all 
components of the model, and (b) they are subjectiv in nature.  This domain is a blend of all the 
various components of health in a comprehensive evaluation.  According to a review by Bjorner 
et al (cited in Ferrans et al., 2005) of 39 studies, thi  concept is supported by the findings that the 
most powerful and consistent predictors of general he th perceptions are physiological 
processes, symptoms, and functional ability.   Ferrans et al. (2005) maintains that while general 
health perceptions are influenced by the previous components of the model, they are different 
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from others. Therefore, it is best to use tools that measure other components, such as symptoms 
or functioning, to evaluate general health perceptions.  General health perception can be 
measured by a single global question regarding how individuals rate their health or through a 
series of questions on the SF-36 (Ware & Sherbourne, 1992).                        
According to Ferrans et al. (2005) when rating their alth, individuals generally consider a 
variety of health aspects as well as the implied meaning of each.  Differences have been found 
between men and women when evaluating health in general (Benyamini, Leventhal, & 
Leventhal, 2000). Women's health ratings are based on a wider range of health-related and non-
health-related factors than are men's.   
Another study in cancer patients showed a reflexology intervention had a positive impact 
on perception of impairment and functional status that included physical and psychological 
function, with implications for general health percption (Wright, Courtney, Donnelly, Kenny, & 
Lavin, 2002).  O'Sullivan (2001) measured the self-p rceived health status of a cohort of breast 
cancer survivors (N=120 women) using the SF-36 questionnaire. The resea ch rs found that the 
health status of the participants was significantly (p<.05) better than that of the comparison 
group in four of the eight domains: social functioning, mental health, vitality, and general health 
perceptions.  No studies were identified that specifically assessed women’s general health 
perception following axillary lymph node surgery.  
Overall Quality of Life  
      The final component of the model, overall quality of life, was defined by Wilson and Cleary 
(1995) as subjective well-being linked to how happy or satisfied a person is with life overall. 
Subjective well-being is a construct that consists of pleasant and unpleasant affect, global 
judgment of life satisfaction, and satisfaction with personal domains of life (Deiner, Suh, Lucas, 
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& Smith, 1999).  Wilson and Cleary (1995) underscored how individuals’ values and preferences 
affect overall quality of life.  Hence, the impact of values must be a part of an assessment of 
satisfaction with life.  Life satisfaction can be masured by a solitary question or through a 
battery of questions about satisfaction with various characteristics of life. Using an instrument to 
measure values is beneficial because it allows the res archer to determine whether values have 
changed over the course of the study.   
 Quality of life benefits of SLNB compared to ALND are not as well documented as the 
benefits of SLNB (Belmonte et al., 2012).  Limitations are absence of pretreatment assessment 
and reliable and valid quality of life tools.   Kootstra et al. (2008) pointed out that two-year, post-
stage I/II breast cancer patients’ quality of life is comparable to quality of life shortly before 
surgery. Emotional function was rated as better than prior to surgery. SLNB was not associated 
with a superior quality of life when compared to ALND. However, as one would expect, 
undergoing systemic therapy and/or experiencing complications unfavorably affects quality of 
life.   
 The Axillary Lymphatic Mapping Against Nodal Axillary Clearance (ALMANC) 
randomized trial comparing SLNB to standard axillary treatment in the management of early 
breast cancer patients included a comprehensive and repeated quality of life assessment over 18 
months (Fleissig et al., 2006). The significant differences in the treatment groups completing the 
Functional Assessment of Cancer Therapy-Breast (FACT-B+4) favored the SLNB group  
throughout the 18-month evaluation,  with the benefit being arm functioning and better quality of 
life in the SLNB group.  
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Background and Overview for Primary Analysis  
The clinical stage of breast cancer guides the surgical approach. American Joint 
Committee on Cancer uses the TNM (T-tumor, N-nodes, M-metastases) system for staging to 
determine breast cancer prognosis (Edge et al., 2010). The most common treatment for women 
with localized breast cancer is surgical excision and staging axillary lymph node evaluation with 
or without radiation therapy.  Based on treatment guideline, staging and prognostic factors, and 
the cancer care provider’s recommendations, a woman ay receive neoadjuvant chemotherapy 
or hormonal therapy administered to shrink a tumor before definitive removal of the tumor. 
Other treatment options are adjuvant chemotherapy, hormonal therapy, or monoclonal antibody 
therapy with the goal of eliminating or delaying disease recurrence (Bradley, 2007). Prognostic 
factors are important indicators at the time of surgery to evaluate the associated disease-free or 
overall survival if no systemic adjuvant therapy is administered (Cianfrocca & Goldstein, 2004).  
Lymph node metastasis is an important prognostic factor for breast cancer. Sixty-one percent of 
woman with invasive breast cancer are estimated to have localized disease (Stage 0-IIB) with 
cancerous cells confined to the original cell layer or to breast lobes or ducts (with no metastatic 
disease in the lymph nodes). Thirty-two percent have regional disease (i.e., spread to regional 
lymph nodes). 
Breast-conserving surgery is considered the standard procedure in early breast cancer 
generally followed by radiotherapy (Kaufmann, Morrow, von Minckwitz, & Harris, 2010). 
Initially after treatment, breast-conserving surgery is credited for providing a better body image 
than mastectomy (Arndt, Stegmaier, Ziegler, & Brenner, 2008). Mastectomy is the treatment of 
choice when there is high risk for local recurrence. Breast-conserving surgery may be 
contraindicated for woman with large tumors in a small breast, persistent positive nodes after a 
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resection, diffuse calcifications, potential poor csmetic outcome, and contraindications to 
radiation therapy (Belmonte et al., 2012). 
Over time, genetic testing of breast cancer tumors may be sufficient to determine the 
need for treatment and replace the need for node biopsies.  The status of the axillary nodes is still 
the most important prognostic factor for directing the impact of treatment.   Reported in the 
ACOSOG-Z0011 phase III randomized trial of ALND in women with stage I or IIA breast 
cancer and positive lymph nodes (Lucci et al., 2007), SLNB has gained preference over ALND 
for the staging of early breast cancer due to less morbidity and the questionable survival benefits 
of ALND. These findings were part of a trend to move away from radical surgery for breast 
cancer. Rates of mastectomy declined in the 1980s after research showing survival rates 
following lumpectomy and radiation were comparable to those after a mastectomy (Fisher et al., 
1989). 
The surgical approach in the primary study (Connor, et al., 2013) was based on findings 
that show identification of the two lymphatic systems in the axilla—those draining the breast and 
those draining the axilla—is possible through injection of a radioactive isotope in the breast for 
SLN identification and injection of blue dye (lymphazurin or methylene blue) into the arm for 
identification of arm lymphatics.   
The primary aim of the study was to gain further knowledge and experience with lymph 
node surgery.  The researchers investigated variations and patterns in arm lymphatic drainage 
that leads to disruption of arm lymphatics during SNLB and ALND. Findings from the primary 
analysis showed that axillary reverse mapping is a feasible procedure for identifying and 
preserving axillary arm lymphatics with an acceptable rate of SLN crossover (Connor et al., 
2013).  A secondary aim was to evaluate variables of quality of life, including pain, and  
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compare between individuals with and without lymphedema.  The statistical analysis for efficacy 
was based on the occurrence of lymphedema rates (with SLNB and ALND) within the first year 
after surgery. The primary analysis used one year estimates as the historical control (i.e. null 
hypothesis) rates against which the observed rates on-protocol were compared.   The sample size 
was determined based on the lymphedema outcomes, and was set to recruit 153 SLNB only 
procedures and 58 ALND procedures (Connor et al., 2013). 
Summary 
 Controversy around quality of life benefits of SLNB compared to ALND in women with 
early breast cancer remains.  The four publications dentified in the literature comparing SLNB 
with or without ALND using axillary reverse mapping are in the early stages (feasibility, phase I, 
and II trials)  (Bedrosian et al., 2010; Boneti et al., 2009; Connor et al., 2013; Ponzone et al., 
2009).  Connor et al. (2013) have collected quality of life data not yet analyzed through the MOS 
SF-36 (Medical Outcomes Study Short Form-36) that will be beneficial to the feasibility of 
axillary reverse mapping to provide direction for patient education and intervention pre- and 
post- axillary node surgery.  To this author’s knowledge there has been no quality of life data 
published comparing SLNB with and without ALND using axillary reverse mapping.    
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Chapter 3 
 Methodology  
 
This section describes the study design, the sample of breast cancer participants in the 
study, the setting, procedures, measures, and data an lysis for  the primary analysis of secondary 
outcomes. The primary analysis is summarized with results of the early findings.  Lastly, ethical 
considerations  and limitations are discussed. 
Study Design and Purpose 
The current proposed study is a primary analysis examining the secondary outcomes not 
previously analyzed in the axillary reverse mapping study.   The purpose of the study is to apply 
the modified  model of Ferrans et al. (2005) (see Figure 1) to evaluate the impact of  individual 
characteristics (age), biological factors (body mass index, SLNB or ALND with or without 
SLNB, chemotherapy)), symptoms (pain and lymphedema), functional status (muscle strength, 
shoulder flexibility, and SF-36 physical function scale score), general health perspective (SF-36 
general health perception score), and overall quality of life (SF-36 physical and mental scores) of 
women with early breast cancer over time during the first two years after surgery. The study will 
evaluate the benefits of the newer axillary reverse mapping procedure on the health-related 
quality of life.  
Research Questions. The following research questions will be explored: Among 185 
patients with clinical node negative or node positive breast cancer recruited for evaluation to this 
prospective non-randomized trial between December 2009 to February 2012: 
1. What are the levels of pain, physical function, general health perceptions, and health 
related quality of life over time (baseline, six months, one year, and two years) for 
women after axillary reverse mapping?  
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2. Are there differences in physical function for women who have had SLNB or ALND with 
our without SLNB and women who did or did not receive chemotherapy measured over 
time (baseline, six months, one year, and two years)? 
3. What is the occurrence of lymphedema (Yes/No) with measures of physical function, 
general health perception, and health-related quality of life) over time (baseline, six 
months, one year, and two years)? 
4. Controlling for an individual characteristics (age), what are the relationships of biological 
factors (body mass index, SLNB or ALND with or without SLNB), symptoms (pain and 
lymphedema), and functional status (SF-36 function score, muscle strength, and 
flexibility) to general health perception and health related quality of life at three separate 
time points (six -months, one year, and two year). (See Figure 1) 
The primary aim of the axillary reverse mapping study was to prevent lymphedema by 
preserving arm versus breast axillary lymphatics.   Adoption of the technique has been limited due to 
concerns regarding feasibility and oncologic safety.  The non-randomized, single-center, Phase II 
prospective study was undertaken to investigate axillary reverse mapping in clinically node negative 
and node positive breast cancer patients.  Conner (2013) reported on 184 participants undergoing 212 
axillary reverse mapping procedures (28 bilateral): 155 SLNB without ALND (Group 1) and 57 
ALNDs with/without SLNB (Group 2).  If they had a SLN, directly entered a SLN, or were within 
ALND boundaries during axillary reverse mapping, lymphatics were not preserved. The potential 
scenarios for injection of lymphazurin or methylene blue dye and radioactive isotope are depicted in 
the Appendix B flow chart (Connor, 2011).  Authors concluded that axillary reverse mapping is a 
feasible procedure for identifying and preserving axill ry arm lymphatics with an acceptable rate of 
crossover.  The secondary aim of the axillary reverse mapping study was:  
1) To evaluate variables of quality of life 
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2) To compare these variables between those individuals with and without lymphedema.   
Sample and Setting  
 All 185 patients were registered with a Midwestern Academic Medical Cancer Center Clinical 
Trials Office to participate in this prospective non-randomized clinical trial between December 2009 to 
February 2012. The Internal Review Board approved trial recruited 185 participants. Axillary reverse 
mapping was attempted during SLNB procedures and ALND with or without a SLNB. Subject 
participation in the study began at the time of their eligibility visit and lasted for three years. Atthe time 
this portion of the study was analyzed not all women had reached three years of follow up. 
Eligible patients included women between the age of 18 to 89 years or older with a 
diagnosis of breast cancer requiring lymph node evaluation for ipsilateral or contralateral breast 
cancer or prophylactic mastectomy. Women who receivd neoadjuvant therapy and clinically 
node positive were allowed to participate. Patients were excluded if they were pregnant or 
nursing, had history of prior axillary procedure, breast augmentation, blue dye allergy, or history 
of lymphedema.  
Procedures  
When a patient presented to the clinic the preliminary evaluation included the standard 
evaluation of the patient’s breast cancer; this consisted of a full history and physical, a clinical 
breast exam, review of relevant imaging studies, and any known pathology (Connor et al., 2013). 
Once the patient met all of the inclusion criteria and if the patient and surgeon agreed on a SNLB 
and/or ALND, the patient was presented with the study protocol. The study then was described 
in detail to the patient who was allowed sufficient time to read over the study details and ask 
questions.  If the patient chose to participate in the study, informed consent was obtained and a 
                                                                             38 
 
HIPPA form was completed by the patient. A dedicated and experience research clinical data 
coordinator was assigned to the study.  
The case report form consists of a set of forms for each participant that provided a record of the 
data obtained according to the study protocol.  Case report forms were completed as scheduled during 
the course of the study (baseline, six months, one year, two years, and three years).  Data needed to 
complete these forms were captured remotely in the web-based comprehensive research information 
system. The medical chart and any other clinical worksheets, and procedural reports were the source of 
verification of the data entered into the study datab se.  Appropriate baseline demographic information, 
required eligibility checklists, required registration forms and a copy of the signed informed consent 
were sent to principal investigator for review to confirm eligibility. The individual then could be 
enrolled in the study.   
Measurements 
 An overview of the measures operationalized for this study are found in Table 1.  
Table 1  
 
Measures for Testing Single-Domain and Multiple-Domain Indicators 
 
Domain Measured Variable 
Individual Characteristics Age 
 
Biological function Body Mass Index, sentinel lymph node biopsy, and axillary 
lymph node dissection, chemotherapy  
Symptom status SF-36 Pain Scale, lymphedema  
Physical function Short-Form health survey (SF-36) physical functioning scale  
score, muscle strength, shoulder flexibility 
General Health Perception SF-36 general health scale ore 
Overall Quality of Life  SF-36 physical and mental scores  
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Age.  Age was recorded during review of the appropriate bseline demographic 
information and on the required eligibility checklists. Date of birth was extracted from the health 
record at a Midwestern medical center.  Date of birth was converted to a continuous age variable.   
 Height and Weight. Height in inches was be collected from the patient r cord. Weight in 
pounds was recorded at baseline, six months, one, and two years. Body mass index was 
automatically calculated by the electronic health reco d (kilograms/meters²).  Body mass index is 
viewed as an accurate way to determine the effect o weight on an individual’s health and can be 
used as an indicator for health status and disease risk (Casey, 2013).  
Chemotherapy. Chemotherapy history was recorded by the coordinator on the 
lymphedema assessment axillary reverse mapping case report form (Appendix C) completed at 
baseline, six months, one, two, and three years.  The categories for chemotherapy were: 
Chemotherapy (Yes/No), Neoadjvant Chemotherapy (Yes/No), and Adjuvant Chemotherapy 
(Yes/No). There is no documentation describing specific chemotherapy regimen on the form. 
Adjuvant chemotherapy rates and total number of patients receiving chemotherapy were factored 
in during the descriptive analysis based information recorded on the lymphedema assessment 
form and the axillary reverse mapping case report form (data not analyzed). For the purpose of 
avoiding reduction of statistical power in analysis patients was categorized as chemotherapy 
yes/no.   
Lymphedema.  According to the protocol patients were scheduled to undergo a total of 
seven arm edema assessments throughout the study. The information for this analysis was 
recorded at baseline, six months, one year, and two years.   No special appointments were 
requested for this monitoring as these assessments coi cided with the standard follow-up for 
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surgical patients. The edema assessment and other measurements were completed by a qualified 
and trained member of the study investigators’ personnel (Connor et al., 2011). 
The edema assessment was performed by measuring the arm circumference in 
centimeters (cm).  Measurements were taken on both arms at the level of the 
metacarpophalangeal joints , wrist, 10 cm above the wrist, at the elbow and 10 cm above the 
elbow.  These measurements were be recorded at the stated intervals and compared to baseline.  
In a study evaluating arm lymphedema following breast cancer surgery.  Taylor, Jayasinghe, 
Koelmeyer, Ung, and Boyages (2006) reported the reliability was 0.97 to 0.98 for 
circumferential measurements.  There was a high correlation (r = 0.98) for circumferential 
measurements and water displacement for measuring in upper-limb volume.  
 For the purpose of these analyses, measurements of the bilateral upper extremities were 
considered at baseline, six months, one, and two years. If an increase of circumferential 
measurement of 2 cm or more compared to baseline occurred, the patient was referred to a 
lymphedema specialist at the Midwestern academic medical center Physical Therapy Department 
for lymphedema evaluation and treatment   A girth difference of more than 2 cm in the involved 
arm versus the uninvolved arm was an accepted criteria for a positive diagnosis of lymphedema 
in clinical practice (Armer & Stewart, 2005). Suspected lymphedema was confirmed by the 
lymphedema specialist in order to be considered as having occurred.   
Muscle Strength. Assessment of grip strength is commonly used to assess hand function. 
Assessment of hand grip strength was conducted by using the DETECTO Digital Handgrip 
Dynamometer (DHS) (DETECTO, 2008), that registers fo ce in pounds per square inch.  The 
manufacturer claimed the device was reliable and accur te, although no evidence to support the 
claim was found. The subject squeezed the dynamometer with maximum isometric effort while 
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keeping the arm at a right angle with the elbow at the side of the body. The best of three trials for 
each hand was recorded, with at least 15 seconds recovery between each effort.  It was 
documented which hand was the dominant hand, as this could affect the results. Documentation 
was recorded on the Lymphedema Assessment axillary reverse mapping case report form 
(Appendix C).  This information was recorded at each ssessment.    
Shoulder Flexibility. Range of motion was assessed by evaluating shoulder movement; 
flexion, abduction, and rotation.  Results were reco ded on the lymphedema assessment axillary 
reverse mapping case report form (Appendix C). The scoring is based on a scale from one to six, 
with one representing almost no movement and six representing full comfortable motion 
(Morimoto et al., 2003).  These measurements were recorded at baseline, six months, one and 
two years and recorded in comprehensive research information system.  
SF-36 Physical and Mental Health Scores. Patients completed a standard measure of 
health-related quality of life, the MOS 36-Item Short-Form Health Survey (SF-36) (Ware & 
Sherbourne, 1992); this was  completed  at each arm assessment throughout the study period. For 
the purpose of analyzing secondary outcomes the baseline, six month, one and two year scores 
were evaluated. Scores were transferred to the Research Electronic Data Capture (RedCap), a 
secure, web-based application developed to support data capture for clinical trials at a 
Midwestern academic medical center.  
The SF-36 is a 36-item, self-administered generic health-related quality of life 
assessment designed to measure eight health attributes (http://www.sf-36.org/demos/SF-
36.html). The SF-36 has been administered successfully in the U.S. general population and other 
countries to various age groups and in specific diseases such as breast cancer (Ware & Gandek, 
1998). The survey can be administered in five to ten minutes. The eight subscales that are part of 
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these general areas of health-related quality of life are: (a) physical functioning, (b) role 
function-physical, (c) bodily pain, (d) social functioning, (e) role-emotional well-being, (f) 
vitality (energy/fatigue), (g) mental health, and (h) general health perceptions. All items, 
subscales and clusters within the SF-36 scale are designed to be scored on a scale of 0-100 with 
100 indicating the most favorable score. The number of responses for each question varies. Self-
reported health transition is the only item out of he 36 not used to score the eight SF-36 scales. 
The eight scales form two separate clusters resulting from the physical and mental health 
variance they share. Factor analytic studies indicate that physical and mental health factors 
account for 80-85% of the reliable variance.  
The identification of the two factors led to the construction of the psychometrically-based 
physical and mental health summary measures (Ware & Gandek, 1998). Physical functioning, 
role-function physical and bodily pain correlates highly with the physical component and are the 
backbone for the scoring of the physical component summary tool. The highest correlation for 
the mental component is with mental health, role-emotional well-being, and social functioning 
scales that contribute to the majority of the mental component summary measure. Vitality, 
general health, and social functioning have notable correlations for both components. General 
health loads higher on Physical Component Summary and vitality and social functioning load 
higher on Mental Component Summary; therefore, theyar  placed in these respective 
components. Reliability for the physical component summary is 0.92 and for the Mental 
Component Summary 0.88.  The primary scales used in the parent study for analysis were the 
Physical and Mental Component Summary Scores.  The scores were recorded on the 
lymphedema assessment axillary reverse mapping case report form (Appendix C).   
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The interpretation of physical component and mental component summary results are 
made easier with the standization of mean scores and t dard deviations (Ware, 2002). For 
example, norm-based scoring is useful to monitor disease groups over time. Linear 
transformations were conducted to transform scores t  a mean of 50 and standard deviations of 
10 in the general population. Scores higher or lower (0 to 100) indicate better or worse quality of 
life compared to the general United States population. 
SF-36 Pain Scale. The SF-36 is a 36-item self-administered generic healt  related quality 
of life assessment designed to measure eight health attributes (Ware & Sherbourne, 1992). Pain 
is one of the eight attributes in the SF-36. Each of t e scales has a score that ranges from 0 to 100 
with a higher score representing a more favorable healt  status. The SF-36 retained the SF-20 
question regarding the frequency of bodily pain or discomfort and added an item regarding the 
extent of interference with normal activities because of pain.  There are a total of two questions 
in the in the pain scale. .  The pain scale reliability is 0.90 (Ware & Gandek, 1998).  
SF-36 Physical Functioning Scale. Physical function is another one of the eight 
attributes in the SF-36 (Ware & Sherbourne, 1992). Each of the ten items within the subscale has 
a range of 0 to 100 with a higher score representing a more favorable physical functioning. The 
Physical Functioning Scale consists of ten items that evaluate several components of physical 
functioning and a range of severe to minor physical l mitation.  The physical functioning alpha 
coefficient value for internal consistency reliability is 0.93 (Ware & Gandek, 1998). 
SF-36 General Health Perception. General Health Perception consists of five items 
(Ware & Gandek, 1998). It correlates highly (r= 0.96) with the 22-item General Health Rating 
Index. The scale evaluates health as poor and likely to get worse versus excellent health. A sixth 
item, asks participants to score the amount of change i  their general status over one year. The 
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item is not used to score any of the eight multi-item scales. Reliably alpha is reported at 0.81. 
(Ware & Gandek, 1998). 
Sample Size Justification 
The sample size for this study was set based on the primary lymphedema outcomes as noted 
in chapter 2 (p. 34).  
Data Analysis 
Data were analyzed by Statistical Package for Social S ience (SPSS) version 21. 
Descriptive statistics include means and standard deviations were reported for the variables in 
each of the research questions along with sample demographics. Coefficient alphas were 
reported for each scale score for this study sample. P values of ≤ .05 were the cut-off value for 
statistical significance in all analyses. 
Specific data analyses were conducted for each of te following research questions:  
1. What are the levels of pain, physical function, general health perceptions and health 
related quality of life over time (baseline, 6-months, 1-year, 2-year) for women after 
axillary reverse mapping procedures? To explore resarch question one, descriptive 
statistics that include means and standard deviations are reported, along with graphing 
group means. Pain, functional status, general health perception and health related quality 
of life are continuous variables (See Table 2).   
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Table 2            
Type of Variables, Scales, Measures, and Ranges Research Question 1 
Variables/Domain Scale # of  
Items 
Measurement Range 
Lymphedema/Symptom Lymphedema 
assessment 
axillary reverse 
mapping form 
2 Categorical 0-1 
Functional 
status/Physical 
Function 
 
 
SF 36 questions  
3-12 
10 Continuous 0-100  Lowest=Very limited in 
performing all PA including 
bathing or dressing 
Highest=Performs all types of PA 
including the most vigorous 
without limitations due to health 
General Health 
Perception 
SP 36 questions 
 1,33,34,35,36 
5 Continuous 0-100        Lowest=evaluates 
health as poor and likely to get 
worse   Highest=Evaluates 
personal health as excellent 
Health Related Quality 
of Life/Overall Quality 
of Life 
SF- 36 Physical 
Component 
Summary (PCS)  
 
 
 
 
 
 
SF- 36 
Component 
Summary (MCS) 
21 
 
 
 
 
14 
 
Continuous 
 
 
 
 
Continuous 
 
0-100 Lowest=Limitations in self-
care, physical, social, and role 
activities, severe bodily pain, 
frequent tiredness, health rated 
“poor”  Highest= No physical 
limitations, disabilities, or 
decrements in well-being, high 
energy level, health rated 
excellent. 
 
0-100 Lowest =Frequent 
psychological distress, social and 
role disability due to emotional 
problems, health rated “poor”. 
Highest=Frequently positive 
affect, absence of psychological 
distress and limitations in usual 
social/role activities due to 
emotional problems, health rated 
“excellent”.  
 
2. Are there differences in physical function for women who have had SLNB or ALND 
with or without SLND and women who did or did not receive chemotherapy measured 
over time (baseline, six months, one year, and two years).   GPower (Faul, Erdfelder, 
Lang, & Buchner, 2007), was used to conduct analysis of variance (ANOVA) repeated 
measures to answer the research question. Using a power of 0.80 (alpha 0.05), medium 
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effect size, two groups and eight measures, the sample size is calculated to be 22. 
According to Raul et al. (2007) an f of 0.25 is a medium effect.                                                                     
Table 3  
Type of Variables, Scales, Measures, and Ranges Research Question 2 
Independent 
Variable 
Scale # of  
Items 
Type of Measurement Range 
Surgical 
Treatment- 
SLNB or 
ALND  
Documented per 
medical records  
2 Categorical 0-1 
Chemotherapy 
Therapy  
Documented on 
axillary reverse 
mapping work sheet 
 
  
2 Categorical  0-1 
 
Dependent 
Variables 
Scale # of  
Items 
Type of Measurement Range 
Functional 
status/Physical 
function 
SF 36 questions 3-12 10 Continuous 0-100  Lowest=Very limited in 
performing all PA including 
bathing or dressing 
Highest=Performs all types of 
PA including the most vigorous 
without limitations due to health 
 
3. What is the occurrence of lymphedema (Yes/No) with measures of physical function, 
general health perception, and health-related quality of life over time (baseline, six 
months, one year, and two years)? For research question three, descriptive analyses 
consisted of graphs of individual values by lymphedema group (yes/no); individual data 
were graphed followed by means and standard deviations hat were tested statistically 
using t-tests. Table 4 gives information about each of the variables used for this analysis.  
Table 4 
Type of Variables, Scales, Measures, and Ranges Research Question 3 
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Variables/Domain Scale # of  
Items 
Measurement Range 
Lymphedema/Symptom Lymphedema 
assessment 
axillary reverse 
mapping form 
2 Categorical 0-1 
 0= No lymphedema.                          
1= lymphedema 
 
Functional 
status/Physical function 
 
 
SF 36 questions  
3-12 
10 Continuous 0-100  Lowest=Very limited in 
performing all PA including 
bathing or dressing 
Highest=Performs all types of PA 
including the most vigorous 
without limitations due to health 
General Health 
Perception 
SP 36 questions 
 1,33,34,35,36 
5 Continuous 0-100        Lowest=evaluates 
health as poor and likely to get 
worse   Highest=Evaluates 
personal health as excellent 
Health Related Quality 
of Life/Overall Quality 
of Life 
SF- 36 Physical 
Component 
Summary (PCS)  
 
 
 
 
 
SF- 36 
Component 
Summary (MCS) 
21 
 
 
 
 
14 
 
Continuous 
 
 
 
 
Continuous 
 
0-100 Lowest=Limitations in self-
care, physical, social, and role 
activities, severe bodily pain, 
frequent tiredness, health rated 
“poor”  Highest= No physical 
limitations, disabilities, or 
decrements in well-being, high 
energy level, health rated 
excellent. 
 
0-100 Lowest =Frequent 
psychological distress, social and 
role disability due to emotional 
problems, health rated “poor”. 
Highest=Frequently positive 
affect, absence of psychological 
distress and limitations in usual 
social/role activities due to 
emotional problems, health rated 
“excellent”.  
 
4. Controlling for individual characteristics (age) what were  the relationships of biological 
factors (body mass index, SLNB or ALND with or without SLNB), symptoms (pain and 
lymphedema), and functional status (SF-36 function) t  general health perception and 
health-related quality of life at three separate time points (six months, one year, and two 
years)? Six multiple regression equations were testd. Separate multiple regressions for 
each of the three time points were conducted and separate multiple regressions for each 
of the two dependent variables: General health perce tions and health-related quality of 
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life. The independent variables were the one individual characteristic (Step 1), and 
biological factors, symptoms, and functional status variables (Step 2) (See Table 5).                 
Based on calculations outlined by Cohen (cited in Green, 1991) a sample size of 89 is 
required to evaluate multiple correlation coefficients with a power of 0.80, (alpha 0.05), 
medium effect size, and five predictors. A sample siz of 103 is required for a medium 
effect size and seven predictors. Using Cohen’s equation f =R²/( R²/-1), f  was calculated 
to be 0.15. Chi-square was used to determine whether there was a statistically significant 
difference in lymphedema between a SLNB only and ALND with or without SLNB and 
lymphedema and the SF-36 scale scores.  
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Table 5 
Type of Variables, Scales, Measures and Ranges Research Question 4 
Independent 
Variable 
Scale # of  
Items 
Type  of 
Measurement 
Range 
Individual 
Characteristics:  
    Age 
Medical Records   
Categorical  
 
 
TBD 
Biological 
factors:  
   Body Mass 
Index 
Medical Records 
 
  
Continuous  
 
 
TBD 
Functional 
status:  
  Physical    
function 
SF 36 questions 3-
12 
10 Continuous 0-100  Lowest=Very limited in 
performing all PA including bathing 
or dressing 
Highest=Performs all types of PA 
including the most vigorous without 
limitations due to health 
Symptoms:  
  Pain 
 
  Lymphedema 
 
SF 36 questions 
 
Lymphedema 
assessment axillary 
reverse mapping 
form 
 
2 
 
2 
 
Continuous  
 
Categorical  
 
0-100 Lowest=Very severe and 
extremely limiting pain. Highest= No 
pain or limitation due to pain.  
0-1 0= No lymphedema.                       
1= lymphedema 
 
Dependent 
Variables 
Scale # of  
Items 
Type of 
Measurement 
Range 
General Health 
Perception 
SP 36 questions 
 1,33,34,35,36 
5 Continuous 0-100        Lowest=evaluates health 
as poor and likely to get worse   
Highest=Evaluates personal health as 
excellent 
Health-Related 
Quality of life/ 
Overall 
Quality of Life 
Physical 
Component 
Summary (PCS)  
 
 
 
 
 
 
 
 
Component 
Summary (MCS) 
21 
 
 
 
 
 
 
14 
Continuous 
 
 
 
 
Continuous 
0-100 Lowest=Limitations in self-
care, physical, social, and role 
activities, severe bodily pain, 
frequent tiredness, health rated 
“poor”  Highest= No physical 
limitations, disabilities, or 
decrements in well-being, high 
energy level, health rated excellent.                                  
0-100 Lowest =Frequent 
psychological distress, social and 
role disability due to emotional 
problems, health rated “poor”. 
Highest=Frequently positive affect, 
absence of psychological distress and 
limitations in usual social/role 
activities due to emotional problems, 
health rated “excellent”.  
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Ethical Considerations 
This investigator was added as a sub-investigator to the parent study. The Human 
Research and Protection Program and Human Subjects Committee were contacted for direction 
on approval of research questions that are a primary analysis of the seconary outcomes.   All 
electronic and paper files are stored in secure, password protected electronic files/systems or in 
locked cabinet files according to the parent protocl. The extent of access to participant data 
within the informatics system was  restricted to an as needed basis.   Data were entered into a 
excel data base by trained study personel. Every tenth entry was checked by this investigator for 
accuracy and if errors were identified every fifth entry was reviewed for accuracy.  
 
Summary 
An analysis examining the secondary outcomes of the primary study was  conducted using a 
descriptive correlational design to explore the  research questions.  Answering the proposed 
questions provided knowledge for  future nursing interventions to improve the quality of life of 
breast cancer survivors with and without lymphedema post axillary reverse mapping prodecure.  
The possible correlation of biological status, symptoms, and functinal  status to quality of life 
may provide insight for tailored intervention among the expanding number of breast cancer 
survivors.  
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Chapter 4  
 
Results 
 
The sample demographics as well as the results for each research question are presented 
in this chapter.  The purpose of this primary analysis examining secondary outcomes was to 
describe pain levels, functional status, general het  perceptions, and health-related quality of 
life over two years for women after axillary revers mapping.  Differences in functional status 
for women who did or did not receive chemotherapy were assessed using a mixed model method.  
A descriptive analysis was conducted for occurrence of lymphedema and measures of functional 
status, general health perceptions, and health-related quality of life over two years.  Because the 
correlation between age and all independent variables was found to be insignificant simultaneous 
regression was performed.  The relationship of individual characteristics, biological factors, 
symptoms, and functional status to general health perception and health-related quality of life 
was evaluated at three time points over two years. 
           Sample Characteristics 
  The final sample size for this study was 185. Due to the focus on longitudinal time points 
participants included in the analysis were those seen at three of the four time points (i.e., before 
surgery, six months, one year, and two years post-surgery).   The majority of participants were 
white (91%). The age in study participants included in the primary analysis of secondary end 
points ranged from 29 to 88 years old (M = 56; SD = 11.4).  The mean body mass index was 
29.3 (SD = 6.8) with a range from 18.2 to 55. Seventy percent of women had a body mass index 
(BMI) of ≥ 25 kg/m² and 40% had a body mass index of ≥ 30 kg/m².  Approximately two thirds 
underwent a SLNB on one or both sides of the axilla compared to one-third undergoing an 
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ALND. Nearly 65% of participants received chemotherapy. Sample demographics are provided 
in Table 6. 
Table 6         
Sample Demographics        
  
Surgery 
Frequency Percentage 
  
    
Axillary Lymph Node Dissection 
 
   Sentinel Lymph Node Biopsy (unilateral)      
     
   Sentinel Lymph Node Biopsy (bilateral)  
 
     Total 
  
 
56 
 
107 
 
22 
 
185 
 
30.3 
 
57.5 
 
11.8 
  
  
Chemotherapy  
  
    
   Yes 
 
   No 
 
   Known 
 
     Total 
  
 
56 
 
121 
 
8 
 
185 
 
30.3 
 
65.4 
 
4.3 
  
  
Race 
  
   
   White 
 
   African American 
 
   Hispanic or Latino 
 
   Asian 
 
      Total 
  
 
169 
 
13 
 
2 
 
1 
 
185 
  
 
91.4 
 
7 
 
1.1 
 
0.5 
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 Lymphedema was also analyzed by ethnicity. The results in Table 7 are a cross tabulation 
of whether lymphedema occurred (or not) and race in order to see if lymphedema differed with 
race. The cross tabulation showed that up to 33% and 37.5% of African American women 
experience lymphedema at one and two years respectively compared to 3.6% and 3.4% of 
Caucasian women at one and two years respectively. No Latino women experienced 
lymphedema.   
Table 7.  
Lymphedema Frequency by Race 
Race No LE LE Frequency Chi-square 
Six Months     
3.61   White 155 7 4.3% 
  African American 11 2 15% 
  Latino 0 0  
One Year     
18.96**   White 160 6 3.6% 
  African American 4 8 33% 
  Latino 0 0  
Two Years     
13.64 **   White 139 5 3.4% 
  African American 5 3 37.5% 
  Latino 0 0  
Note. **=p ˂  0.001 ;   LE= Lymphedema 
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Sample Descriptives 
 
 Health-related quality of life was evaluated befor surgery and six months, one year, and 
two years post-surgery. The SF-36 (Ware & Sherbourne, 1992) was used. Scores for the 
subcategories were calculated using standardized procedure where scores higher or lower (0 to 
100) indicate better or worse quality of life, respctively, compared to the general United States 
population.   
Research Question One 
 
The first research question was: What are the levels of pain, physical function, general 
health perceptions and health related quality of life (mental component summary and physical 
component) over time (baseline, six months, one year, and two years) for women after axillary 
reverse mapping procedures?  Table 8 lists the summary statistics for level of pain, functional 
status, general health, physical component status, nd mental health status.   
Table 8  
Descriptive Statistics for SF-36 Scale Measures at Four Time Points 
Time Pain Physical 
Function 
General Health Total PCS Total MCS 
 M(SD) M(SD) M(SD) M(SD) M(SD) 
Baseline 75.01 (23.80) 79.29 (23.84) 73.85 (18.74) 50.00 (9.54) 50.00 (10.00) 
6 Months 77.09 (21.04) 78.69 (24.84) 73.75 (18.13) 50.01 (9.98) 50.00 (9.99) 
1 Year 74.52 (23.90) 75.91 (26.04) 70.00 (19.51) 50.00 (9.99) 49.89 (10.00) 
2 Year 73.62 (23.53) 75.77 (26.39) 72.03 (19.89) 50.02 (12.60) 50.00 (10.00) 
Note. M = mean; SD = standard deviation; PCS = physical component summary score; MCS = 
mental component summary score. 
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 The mean level of pain, physical function, and general health, are consistently more 
favorable at baseline and six months post-surgery. Scores were lower at one year and two years 
post-surgery (see Figure 2). Standardized physical component and mental component summary 
scores show no variance over time.   
Figure 2.  Mean Levels of Pain, Physical Function, General Health, and Physical Component 
Status (PCS) and Mental Component Status (MCS) by Time Periods (baseline, 6 months, 1 year, 
and 2 year). 
 
 
Research Question Two 
 Research question two was to determine if there wer  any differences in physical 
function for women who had SLNB or ALND with or without SLNB and women who did or did 
not receive chemotherapy measured over time (baseline, s x months, one year, and two years)?   
Table 9 shows the means and standard deviations for functional status at the four time point for 
those receiving chemotherapy and those not receiving t. 
 
40
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Baseline 6 months 1 year 2 year
Pain Physical function General health PCS MCS
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Table 9 
Means and Standard Deviations of Physical Function at Four Time Points in Chemotherapy 
(yes/no) Participants 
                                                       Chemotherapy                                              No Chemotherapy   
 
Time                                                     M (SD)                                                              M (SD) 
                                            
Baseline 
   Physical Function                           78.66 (24.84)                                                         81.27 (21.07)                                 
Six months                                      
   Physical Function                           77.64 (26.00)                                                          81.27 (23.30)     
One year  
   Physical Function                          73.11 (26.70)                                                      79.12 (25.51)  
Two year 
   Physical Function                         73.78 (25.90)                                                       80.65 (25.97)  
 
Note. M = mean; SD = standard deviation 
A repeated-measures ANOVA assessed whether there was a difference between the 
average functional status scores at four time points for those receiving chemotherapy versus no 
chemotherapy and surgery (SLNB or ALND with or without SLNB). Testing the assumptions for 
repeated measures, the assumption of normality was met; however, the assumption of sphericity 
was violated. Results for the functional status leve s in the chemotherapy (yes/no) group 
indicated that participants did rate the same over th  four time periods. Using Huynh-Feldt 
correction because Epson was › .75 (Leech, Barrett, & Morgan, 2008, p 160), the within subject 
effect (time) was not significant. While the  means in Table 8 and Figure 3 appear higher in the 
no chemotherapy group there was no significant difference between the chemotherapy and no 
chemotherapy groups in a between group analysis.  
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Figure 3.  Differences in Mean for Physical Function in Participants Receiving Chemotherapy 
Versus no Chemotherapy. 
 
 
Findings for the physical function levels in the surgery (SLNB or ALND) group indicated 
that participants did not rate the same over the four time periods (see Table 10).  
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Baseline 6 months 1 year 2 year
Chemotherapy No Chemotherapy
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Table 10 
Means and Standard Deviations of Physical Function at Four Time Points According to Type of 
Surgery   
                                                   Axillary Lymph Node                                     Sentinel Lymph Node                                  
                                                     Dissection                                                            Biopsy 
    Time                                           M (SD)                                                                     M (SD) 
                                            
Baseline 
   Physical Function                         84.53 (18.77)                                                         79.39 (23.55) 
Six months                                      
   Physical Function                         75.37 (22.23)                                                         80.50 (25.64)     
One year  
   Physical Function                         71.19 (27.36)                                                          78.13 (24.89)  
Two year  
   Physical Function                         67.97 (30.60)                                                           80.08 (23.72)  
 
Note. M = mean; SD = standard deviation 
Huynh-Feldt was used again because Epson was › .75. The within subject effect (time) 
was significant (F (2.54, 354.01) = 3.06, p ‹ .05).  Examination of the means (see Figure 4) indicate a 
significant decrease in mean scores from baseline compared to six months in the ALND group (F 
(1,139) = 6.06, p ‹ .05). There was no significant difference between surgery groups in the between 
group analysis F (1,139) = 2.9, p = 0.91. However the time main effect was qualified by a 
significant interaction between time and surgery, F (2.55, 354.1) =3.06, p ‹ .05. 
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Figure 4.  Differences in Functional Status for Participants with Sentinel Lymph Node Biopsy  
or Axillary Lymph Node Dissection with or without Sentinel Lymph Node Biopsy 
 
 
 
Research Question Three 
 Research question number three was to assess the occurrence of lymphedema with the 
measures of physical function, general health perception, and health-related quality of life over 
time (six months, one year, and two years)?  Individuals with baseline lymphedema were 
excluded from the study.  Lymphedema in the SLNB group diminished over time in contrast to 
an increase over time in the ALND with or without SLNB group (see Table 11). Total 
lymphedema ranges from 5.1% to 5.6% during the two years after axillary surgery.  
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                                                                             60 
 
Table 11  
Clinical Findings in the SLNB, ALND, and Group Totals During the Two Years after Surgery  
                                                   SLNB                        ALND                   Total                                 
                                                   %                               %                        %                              P 
Objective lymphedema                                                                                                                                     
     Six months                           3.3                    9.4                            5.1                             0.13 
     One year                               3.2                     11.1                           5.6                              0.68 
     Two years                             1.8                    14.0                           5.2                              0.01** 
Note. **p= ≤0.01; SLNB = sentinel lymph node biopsy; ALND = axillary lymph node dissection 
Descriptive statistics for variables— pain, physical function, general health, mental 
component summary, and physical component— in participants with and without lymphedema at 
three time points are shown in Table 12.  The number of individuals with lymphedema is 
considerably less than those with lymphedema.  
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Table 12 
Statistics from SF-36 Scale in Participants with or without Lymphedema 
                                         No Lymphedema                                    Lymphedema 
 
                                              M (SD)                n               M (SD)                          n                           
Six Months 
   Pain 77.35 (21.40) 151 89.58 (13.45) 6 
   Physical Function            79.32 (24.67) 154 76.67 (27.51) 6 
   General Health 74.33 (17.92) 152 70.83 (13.20) 6 
   Physical Component  
   Summary 
 
50.24 (9.95) 162 48.05 (12.65) 7 
   Mental Component  
   Summary 
50.05 (10.01) 152 48.66 (13.18) 9 
One Year 
   Pain 75.02 (22.84) 150 61.56 (39.64) 8 
   Physical Function            76.42 (25.61) 151 62.22 (35.45) 9 
   General Health 70.93 (18.27) 151 53.89 (28.26)  9 
   Physical Component  
   Summary 
50.39 (9.62) 152 42.79 (14.12) 9 
   Mental Component  
   Summary 
50.40 (9.79) 152  42.55 (11.66) *  9 
Two Years 
   Pain 75.85 (22.60) 142 54.64 (15.91) 7 
   Physical Function            76.91 (24.76) 145 68.75 (31.71) 8 
   General Health 72.77 (19.15) 143 61.88 (23.44) 8 
   Physical Component  
   Summary 
50.95 (11.59)  146      41.31 (11.73) * 8 
   Mental Component  
   Summary 
50.58 (9.63) 146      46.56 (7.08)  8 
*p=  ≤0.05; M = Mean; SD = Standard Deviation 
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The means of the variables at three time points are depicted for the women with no 
lymphedema (see Figure 5) and for women with lymphedema (see Figure 6). At the six month 
analysis pain scores were higher (favorable) in the lymphedema group compared to the non-
lymphedema group although not statistically significant. General health, mental component 
summary, and physical component summary scores were most favorable in the non-lymphedema 
group compared to the lymphedema group. There is a statistically significant difference between 
the lymphedema and non-lymphedema groups with mental component summary at one year, t 
(159) = 2.31, p = 0.02 and with physical component summary at two years, t (154)  = 2.29, p= 0.02.  
At one and two years, physical function, pain, general health, mental component summary, and 
physical component summary scores were most favorable in the non-lymphedema group.    
 
Figure 5.  Physical Function, General Health Perception, and Health Related Quality of Life 
(physical component summary and mental component summary) in Women with no 
Lymphedema During the Two Years after Surgery  
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Figure 6.  Physical Function, General Health Perception, and Health Related Quality of Life 
(physical component summary and mental component summary) in Women with Lymphedema 
During the Two Years after Surgery 
 
 
Research Question Four 
Research question number four was: Controlling for an  individual characteristic (age), 
the relationships were  explored of biological factors (body mass index, SLNB or ALND with or 
without SLNB), symptoms (pain and lymphedema), and physical function to general health 
perception and health-related quality of life at three separate time points (six months, one year, 
and two years).  Separate multiple regressions for each of the three time points were conducted 
with separate regressions for each of the dependent variables: general health perceptions and 
health-related quality of life (mental component summary and physical component summary). 
The independent variables were age, body mass index, surgery, pain, lymphedema, and physical 
function. There was no variability on any of the flxibility scores, and consequently, these were 
not entered into the regression analysis. Prior to interpreting the regression analysis each model 
40
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was evaluated for the main assumptions of regression. The residuals for normality were assessed 
using PP plots, the constant variance assumption by examining scatter plots of the residuals by 
predicted values. All PP plots approached line of normality and no pattern was identified in the 
scatter plot indicating the data meet the assumptions of errors being normally distributed and 
variances of the residuals were constant. 
General Health. Multiple regression was conducted to determine the best linear 
weighted combination of age, body mass index, surgical procedure, pain, lymphedema, and 
functional status for predicting eneral health. The correlation between age and all independent 
variables was found to be insignificant therefore simultaneous regression was performed.   
According to Leech, Barrett & Morgen (2008, p 95) a high correlation is 0.50 or 0.60 and above 
causing concern with multicollinearity problems. The correlation matrix showed the highest 
correlation between six month pain and general healt  to be 0.46, one year general health and 
pain was 0.46, and two year general health and physical function was 0.41. The combination of 
all seven variables significantly predicts general health at six months, one, and two years (see 
Table 13). The variance at six months, one year, and two years is 27%, 27%, and 23% 
respectively, explained by the linear weighted combination of all variables. According to Cohen 
(cited in Green, 1991, p. 501), there was a  large effect at all three time points.   The beta weights 
(see Table 13) suggest that lower pain levels and a higher physical function score contribute 
most to predicting favorable general health scores at all three time periods. The zero order, 
partial, and part correlations are in descending order.  The flexibility variables were not 
correlated with the dependent variable and removed from the analysis.  
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Table 13 
Simultaneous Multiple Regression Analysis Summary for General Health   
  6 Months 1 Year 2 Years 
Variable b          SEB  β  b         SEB  β b          SEB  β 
Age 0.26 0.13 0.16 0.19 0.15 0.11 0.19 0.16 0.10 
BMI  -0.44 0.21 -0.04 -0.34 0.23 -0.12 -0.5 0.25 -0.16 
Surgery 2.45 2.81 0.06 -1.15 3.10 -0.03 -1.02 3.50 -0.02 
Pain 0.32 0.07 0.39** 0.27 0.07 0.33** 0.20 0.08 0.23* 
Lymphedema -11.01 7.15 -0.12 -12.03 6.70 -0.14 -0.96 8.27 -0.01 
Physical Function 0.16 0.06 0.22** 0.15 0.07 0.19** -0.22 0.08 0.26** 
Muscle Strength 0.45 0.21 0.17 -0.20 0.28 0.01 0.51 0.31 0.14 
   Summary Statistics for the Three Time Period Models   
  6 Months 1 Year 2 Years 
  
                                     R²        Adjusted R²       F             R²         Adjusted R²     F          R²        Adjusted R²       F 
  0.31 0.27 8.68 0.30 0.27 8.64 0.27 0.23     6.70 
Note. p*  ˂ 0.05   p**  ˂0.01 , p** ‹0.01 in all models, b= unstandardized  coefficient , SEB= standard error of b , 
β= standardized coefficient 
 
  Mental Component Summary. Three separate multiple regressions were again 
conducted to establish the best linear weighted combination of age, body mass index, surgical 
procedure, pain, lymphedema,  functional status and muscle strength for predicting the mental 
component summary. The correlation matrix showed th highest correlation between six month 
pain and mental component summary is 0.53, one year m ntal component summary and pain is 
0.50, and two year mental component summary and pain is 0.58. The seven variable linear 
weighted combination significantly (p ‹ 0.01) predicted MCS as indicated in the model summary 
at six months, one year, and two years (see Table 14).  The findings indicate that 33%, 31% and 
37% of variance was explained at six months, one year, and two years, respectively, in the 
mental component summary model. The beta weights, pre ented in Table 13 indicate that pain 
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and functional status contributed the most to predicting the mental component summary scores. 
The zero order, partial, and part correlations are in descending order and the adjusted R² is not 
substantially smaller than the R² therefore no suppression is suspected.  
Table 14 
Simultaneous Multiple Regression Analysis Summary for Mental Component Summary  
  6 Months 1 Year 2 Years 
Variable  b          SEB  β  b         SEB  β  b          SEB  β 
Age 0.01 0.00 0.00 0.10 0.07 0.12 -0.13 0.06 -0.02 
BMI  -0.47 0.09 -0.04 -0.01 0.11 0.01 0.03 0.10 -0.02 
Surgery -0.26 1.19 -0.02 0.68 1.54 0.03 0.11 1.37 0.01 
Pain 0.15 0.03 0.41** 0.13 0.03 0.33** 0.17 0.03  0.44* 
Lymphedema -1.27 3.02 -0.03 -5.07 3.33 -0.11 2.87 3.25 0.06 
Physical Function 0.09 0.03 0.29** 0.20 0.03 0.31** 0.11 0.03 0.30** 
Muscle Strength -0.02 0.09 -0.02 0.33 0.14 0.20 -0.03 0.12 -0.02 
   Summary Statistics for the Three Time Period Models   
  6 Months 1 Year 2 Years 
  
                                     R²        Adjusted R²       F             R²         Adjusted R²     F          R²        Adjusted R²       F 
  0.36 0.33 12.63 0.34 0.31 10.24 0.41 0.37     12.27 
Note. p*  ˂ 0.05   p**  ˂0.01 , p** ‹0.01 in all models, b= unstandardized  coefficient , SEB= standard error of b , 
β= standardized coefficient 
                     
 Physical Component Summary. Next, three separate multiple regressions were 
conducted to establish the best linear weighted combination of age, body mass index, surgical 
procedure, pain, lymphedema,  physical function, and muscle strength for predicting the physical 
component summary.  The correlation matrix showed pain and physical component summary 
had a correlation ranging between 0.798 and 0.803 among the three time points. The correlation 
between physical function and physical component summary ranged from 0.72 to 0.79 at three 
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time points. Physical function and pain were removed from the combination as they were scored 
as a component of the physical component summary (dependent variable).  A five variable linear 
weighted combination significantly (p ‹ 0.01) predicted physical component summary as shown 
in the model summary of Table 15 at one year and two years only.  No single or combination of 
variables predicted physical component symptoms at six months. The findings indicate that 16%, 
and 9% of variance was explained at one year and two years, respectively, in the physical 
component summary model. Increased body mass index, surgery and muscle strength were the 
best predictors of physical component symptoms at one year and increased body mass index and 
muscle strength at one and two years.   
Table 15 
Simultaneous Multiple Regression Analysis Summary for Physical Component Summary  
  6 Months 1 Year 2 Years 
Variable b          SEB  β b         SEB  β b          SEB  β 
Age -0.66 0.08 -0.07 -0.34 0.18 0.16 0.33 0.19 0.16 
BMI  -0.17 0.13 -0.11 -0.73 0.28 -0.21** -0.98 0.31 -0.27** 
Surgery -0.45 1.86 -0.02 9.36 3.93 0.18 4.59 4.38 0.09 
Lymphedema -2.21 4.42 -0.04 0.59 8.34 -0.01 -10.65 9.94 -0.10 
Muscle Strength 0.16 0.12 0.01 1.30 0.33 0.34** 0.75 0.38 0.18* 
   Summary Statistics for the Three Time Period Models   
  6 Months 1 Year 2 Years 
  
                                     R²        Adjusted R²       F             R²         Adjusted R²     F          R²        Adjusted R²       F 
  0.20 -0.01 0.57 0.19 0.16 6.82 0.13 0.09     3.85 
  0.20 -0.01 0.57 0.19 0.16 6.82 0.13 0.09     3.85 
Note. p*  ˂ 0.05   p**  ˂0.01 , p** ‹0.01 in all models, b= unstandardized  coefficient , SEB= standard error of b , 
β= standardized coefficient 
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Summary 
An important finding from this study was that the man level of pain, physical function, 
general health, and physical component status were most favorable at six months post-surgery 
and least favorable one year post surgery. Levels improved at two years post-surgery, but did not 
recover to baseline levels.  The mean level of mental components summary was highest (more 
favorable) at baseline and lowest (less favorable) at one year post surgery returning to near 
baseline levels at two years post-surgery. Mental component summary scores and physical 
component summary scores were similar.  There was no statistical difference in physical 
function levels between women who had SLNB only or ALND or between those receiving 
chemotherapy versus no chemotherapy.  There was a significant difference in the within subject 
effect (time) for surgery.  Mean scores for functional status were significantly higher at six 
months compared to baseline regardless of the type of surgery. Women with lymphedema have a 
significantly lower mental component summary score at one year than those without 
lymphedema.   
 Multiple regression analyses showed that lower pain scores and higher physical function 
contribute the most to the prediction of more favorble general health scores at all three time 
points. Pain and functional status scores contributes the most to predicting mental component 
summary scores at all three time points. Lower body mass index, surgery, (SLNB or  ALND 
with or without SLNB) and greater muscle strength were the best predictors of higher physical 
component summary scores at one year and a lower body mass index and greater muscle strength 
at two years was the best predictor for a favorable physical component summary score.    
 
 
 
                                                                             69 
 
Chapter 5 
Discussion 
Chapter five presents a discussion for the findings from the primary analysis examining 
secondary outcomes using a descriptive correlational design to determine factors that predict 
quality of life after axillary reverse mapping with sentinel lymph node biopsy or axillary lymph 
node dissection with or without sentinel lymph node biopsy. Theoretical relevance and clinical 
application are reviewed. The strengths and limitations of the study are discussed and 
recommendations for future research are presented.  
Summary of Study Findings 
 Quality of life benefits of SLNB compared to ALND with or without SLNB are 
inconsistent in the literature. Many studies have us d quality of life questionnaires alone with 
patient reports of lymphedema. Little is known about the quality of life benefits of a newer 
procedure, axillary reverse mapping.  The researcher has worked as a clinician with breast cancer 
patients for over 15 years and frequently provided education on lymphedema prevention and 
related complications. As a nurse practitioner the researcher saw patients with complications 
extending from a few months to many years post axillary surgery.  
The current study is one of the first to conduct a descriptive analysis of pain levels, 
functional status, general health perceptions, and health related quality of life in breast cancer 
survivors for two years after axillary reverse mapping in lymph node positive and negative breast 
cancer and to examine variables that predict quality of life components. The findings from this 
study suggest women may need the greatest support from health care providers at one year post 
surgery irrespective of their surgical procedure or the apy. Results also suggest that education 
and guidance around lymphedema prevention is increasingly important at baseline and continues 
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as time goes on particularly for those women undergoing axillary reverse mapping in 
combination with ALND with or without SLN biopsy.   General health, mental component 
summary, and physical component summary were most favorable in the non-lymphedema group 
although a group of individuals with lymphedema is not well represented in this study.   
Characteristics of the Individual 
Age. The mean age of 56 years in this study was younger than in other studies referenced 
(Belmonte, et al.,2012; Boneti et al., 2009). Twenty percent of women were ≥ 65 years old. 
There is a similar mean age amongst SLNB participants of 55.5 years (SD = 12.72) and ALND 
participants of 55.7 years (SD = 10.82) with or without SLNB that differs from other studies 
where older women were more likely to undergo SLNB (Yi et al.,2010). Controlling for age had 
no impact in determining the best predictive model for the dependent variable of interest. While 
age contributed variance to the predictive models of general health, physical component 
summary, and mental component summary it was not a significant predictor.  
Biological Function 
Body Mass Index. Nearly 60% of the United States population are overweight or obese, 
and similarly  66% of women are overweight or obese at the time of a breast cancer diagnosis.  
Obesity is defined as a body mass index (BMI) of ≥ 30 kg/m² and overweight as body mass 
index of ≥ 25 kg/m² (World Health Organization, 2011). The rate of overweight or obese at the 
time of breast cancer diagnosis in this group of women was 70% (M = 29.3, SD 6.8) potentially 
placing them at higher risk for co-morbidities and other complications. In this study increased 
body mass index (BMI) significantly contributed to the lower physical component summary 
scores at one and two years suggesting women who are he vier post-surgery may have more 
physical challenges.  
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Chemotherapy.  A good portion of women in the study received neo-adjuvant or 
adjuvant chemotherapy (65%).  Specific type of chemotherapy was not collected for the analysis. 
Anticipated short-term side effects of chemotherapy re hair loss, nausea and vomiting and are 
likely dependent on the drug therapy (Komen, 2013).  Long-term more common side effects of 
chemotherapy may include early menopause, weight gain, fatigue, cognitive dysfunction, and 
neuropathy that may impact quality of life in a breast cancer survivor.  The incidence of the 
potential side effects related to chemotherapy was not collected. While the mean scores in this 
study were higher (more favorable) in the no chemotherapy group there was no significant 
difference in functional status between the chemotherapy and no chemotherapy groups. Albeit 
non-significant, clinically the findings suggest tha  patients receiving chemotherapy may need 
greater support and evaluation at one year post-surgery and beyond.  
Symptoms 
Pain.  The mean pain levels are highest (most favorable) at baseline  and six months 
post-surgery. Scores were lower (less favorable) at one year and continued to deteriorate at two 
years post-surgery. The mean and standard deviation scores in the United States general 
population are 75.2 and 23.7, respectively, indicating that scores are in range with the general 
United States population (Ware, 1994). With that said, decline after six months suggests the need 
for health care providers to monitor and address change in pain levels.   Hormonal therapy is 
prescribed to hormone receptor positive women in the adjuvant setting after surgery or 
chemotherapy.  In trials comparing the overall quality of life in women receiving various 
hormonal medications compared to those not receiving treatment, there were no differences 
found in the quality of life between groups (Ochayon, Zelker, Kaduri, & Kadmon, 2010).  On the 
other hand, there were variations in the different symptoms experienced depending on the 
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hormone they were taking. Hence, joint and muscle ahes can be symptoms with hormonal 
therapies and can unfavorably impact quality of life. It would be reasonable to think that women 
with hormone receptor positive breast cancer may be starting hormonal therapy following their 
six month post-surgery visit. It is hypothesized that this may add to the increased pain levels at 
one and two years.  
Swenson, Nissen, Leach, & Post-White (2009) reported that women with lymphedema 
and their matched controls did not differ significantly in quality of life when taking hormone 
therapy. Based on the literature review and the fact that the history of hormonal therapy was not 
recorded on the case report form, it was not evaluated s a factor for determining quality of life 
in this group.  A lower pain level significantly contributed to more favorable general health and 
mental summary component scores at six months, one year, and two years suggesting it is 
important symptom to assess in patients at every clinica  visit 
Schrenk, Reiger, Shamiych, & Wayand (2000) compared m circumference, subjective 
lymphedema, and pain in women with SLNB and ALND (n= 35). The length of follow up post 
operatively was 15.4 months in the SLNB group and 17.0 months in the ALND group (range, 4-
28 months). Results showed a higher rate of objectiv  lymphedema in woman undergoing an 
ALND when compared to a SLNB, but it was only significantly higher at two years.  The 
findings from this study are partially consistent wi h that of Swenson et al. (2002). Pain was 
greater in the ALND group compared to the SLNB group at one month, six months, and 12 
months post-surgery. On the other hand pain intensity decreased with an increased amount of 
time patients were out from surgery.   
Arm Circumference/Lymphedema. The lower rate of lymphedema in the SLNB group 
and the decline in occurrence in this study are consistent with the literature (3.3%, 3.2%, and 
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1.8% respectively at six months, one year, and two years) (Swenson, et al., 2002).  Contrary to 
this, the rates of lymphedema increased in the ALND group at 9.4%, 11.1%, and 14% at six 
months, one year, and two years,respectively and are consistent with reports in the literature 
(Ashikaga et al., 2010; Mansel et al., 2006).  In this study the mean of SF-36 variables (pain, 
physical function, general health, physical component summary and mental component 
summary) are considered at three time points for women with no lymphedema and for those with 
lymphedema (Table 12). Mental component summary score  at one year and physical component 
summary scores at two years are significantly higher in the non-lymphedema group.  The 
number of women with lymphedema is low and typically the variance in this group is larger 
which likely contributes to the lack of statistical difference between groups. Clinically SF-36 
scores appear more favorable in the non-lymphedema group compared to the lymphedema group 
with the exception of pain scores in the six month group. No lymphedema contributes to 
favorable scores in the general health perception, mental component summary, and physical 
component summary models.   
Functional Status 
SF-36 Physical Function Score. According to Ware and Gandek (1998) the mean SF-36 
physical function score for the general U.S. adult population is 84.2 (SD = 23.3). Women in this 
study have a mean physical function score lower than e general U.S. population. The physical 
function score gradually declines from base line to tw  years post-surgery. There is no 
significant difference in physical functioning score between chemotherapy and no chemotherapy 
or between time periods. There was a significant difference in baseline mean scores between the 
surgical procedures. Women undergoing an ALND had more favorable scores at baseline than 
those undergoing SLNB and ultimately experienced a significant decrease in the mean physical 
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functioning scores. The mean scores for the SLNB group showed a slight improvement. The 
findings indicate that women with a higher functioning score tended to receive the more 
aggressive surgical procedure.  
Muscle Strength. This study evaluated the muscle strength in a regression as an 
independent variable and did not compare the difference between the affected and non-affected 
arm strength. Rietman et al (2004) found no significant difference in grip strength between the 
affected and non-effected side. Grip-strength was an important factor in the following three SF-
36 subscales: physical functioning, role limitation physical and role limitation emotional. The 
contribution of muscle strength to the general healt  model, mental component summary, or 
physical component summary in this study is minimal. The three subscales (physical functioning, 
role limitation physical and role limitation mental) were not studied separately, but as a 
component of mental component summary and physical component summary.   
SF-36 General Health Perception. The mean general health score for the general US 
population is 71.9.  The general health score for this study are highest at baseline and lowest at 
one year (see Table 7).  Findings are comparable to tha  of O’Sullivan (2002) reporting a SF-36 
general health perception score of 71.5 in a cohort of breast cancer survivors. No studies were 
found that specifically examined general health perception in breast cancer patients after axillary 
lymph node surgery. General health perceptions havebeen shown to be connected to biological 
and physiological factors according to Wilson & Cleary (1995). Due to the large number of 
factors affecting health perception it important to consider the variability of each individuals 
unique situations.  
SF-36 Physical and Mental Health Scores.  The mean scores for physical component 
summary and mental component summary are 50 and staard deviations of 10 in the general 
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population after a linear transformation (Ware, 2002). Mean scores in this study at the four time 
points were very near 50 for physical component summary and mental component summary. The 
baseline physical component summary are nearly identical in a similar study of women 
undergoing ALND or SLNB (Belmonte et al., 2012) while the mental component summary and 
physical component summary scores from the similar study at six and 12 months are below the 
mean of 50 (ranging from 47.52-42.76).  The differences in physical component summary and 
mental component summary scores among women with and without lymphedema at one and two 
years are displayed in Table 12. Belmonte et al. found a significant decline (p = ˂ 0.001) in 
mental component summary and physical component summary scores at one month, six months 
and twelve months when compared to baseline. A Belgium long-term evolution of quality of life 
study of women beyond 5 years found that the longer the survival time the more quality of life of 
breast cancer treated patients improved and the less br ast cancer had an impact on the quality of 
life (Neyt & Albrecht, 2006).  
Theoretical Relevance.  The research model was revised based on results of this study 
and the associations with recent literature (See Figure 7).  
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Figure 7. Domains Predicting Quality of Life Post-Axillary Lymph Node Surgery 
 
In this study the domains were examined as simultaneous and independent predictors for 
general health perception, physical component summary, and mental component summary. 
Because predictive factors for mental component summary and physical component summary 
differ they were separated in the final model. Age was removed as a linear component and 
repositioned as a simultaneous factor.  Individual ch racteristic, biological function, symptoms, 
and physical function all contributed to general health perception, physical component summary 
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and mental component summary. The level of contribution for each domain varies somewhat 
with each dependent variable. In general higher physical functioning and lower pain scores 
contributed the most to the prediction of general health perception and mental component 
summary.  Lower muscle strength and higher body mass index significantly predicted lower 
physical component summary scores.  
Implications for Practice 
In this study it could be concluded that health care professionals are doing a reasonable 
job of managing the breast cancer patients’ perception of issues affecting quality of life (pain, 
physical functioning, general health, physical compnent summary and mental component 
summary) within the first six months post-surgery. The diminishing quality of life scores at one 
year and two years compared to baseline and six months may be a result of less frequent contact 
and encouragement from providers post completion of therapy and/or side effects with the start 
of hormonal therapy. It may be that women need additional follow up calls for assessment of 
symptoms and the option for more frequent visits afer their six month post-surgery visit. 
Pain is common symptom experienced from cancer diagnosis through survivorship 
(Oncology Nursing Society, 2013).  As a result of the breast cancer or treatment, pain causes 
significant physical and psychosocial challenges.  Pain uniquely impacts the quality of an 
individual’s life, increases vulnerability and creat s dependence on healthcare providers to assess 
for acceptable management. Because oncology nurses embrace holistic care and have ongoing 
contact with women throughout the continuum of care, th y are in a position to identify 
undertreated or untreated physical or mental conditions and advocate for its relief.  
 Discussion from the breast cancer survivorship care plan should review suggestions to 
reduce risk of lymphedema such as maintaining a healthy weight, avoiding tight fitting clothes, 
                                                                             78 
 
and avoiding injections and intravenous infusions in the affected arm. Tools such as the 
American Cancer Society’s (2014) guideline to physical activity and nutrition should be used for 
education on core exercise and upper body strengtheing and healthy eating.  
   Study findings will be useful to establish priorities for nursing interventions to enhance 
quality of life in breast cancer survivors’ post-axillary surgery. Implementation of survivorship 
care plans related to adverse effects of surgery, chemotherapy, overweight or obesity, physical 
fitness level and should receive more attention and regular evaluation of quality of life in breast 
cancer patients (American Society of Clinical Oncology, 2014).   
It is important for women to know what to anticipate fter treatment. Patient recorded 
information on progression of quality of life can be of great value to healthcare providers in the 
management of breast cancer survivors perceptions. Results can be used to encourage patient 
who are newly diagnosed with breast cancer or for th se who are lacking confidence in towards 
making progress with quality of life components. When informing women undergoing axillary 
surgery education must include the fundamental differences in various aspects of quality of life 
overtime. The epidemic of obesity must also be considered in planning patient procedures and 
care. Health care providers may obtain patient resources through replicable organizations for 
example the American Cancer Society (2014), Livestrong Foundation (2014), Oncology Nursing 
Society (2014), and Susan G. Komen (2013). Cancer Survivorship Training (CST) (Klemp, 
2014) is an e-learning education and training tool  help healthcare providers meet their 
professional needs and improve the lives of cancer patients in areas such as energy balance, 
psychosocial issues, physical and late long term effects of cancer and its treatment. For the two 
year period evaluated the higher risk for threat to quality of life may be at the one year time 
period and is most prevalent in women. As a member of interdisciplinary teams involved in 
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practice, education, administration, and research on ol gy nurses must take a vital position 
quality of life management.  
Study Strengths and Limitations 
 The study was a preplanned prospective analysis which el minates bias of a 
retrospective trial.  Collection of pre-surgery baseline data allowed for interpretation of changes 
in quality of life over time. The present study used valid and reliable measurement tools and 
objective measurements to evaluated quality of life in breast cancer survivors’ post-axillary 
lymph node surgery.   
Some limitations should be taken into account. A risk of bias or threat to internal validity 
exists because there was no control group, no blinding, and no random assignment.  Because 
weight measurment was not a primary objective of the study there was no protocol or standard 
procedure for measuring height and weight such as removal of shoes, standardized scale, 
measuring the patient in street clothes or a gown. Data on social and physical components were 
not gathered therefore control of enviromental characteristics was  possible.  The sample size 
was based on the primary objective, therefore women undergoing SLNB (n=129) without ALND 
compared to those with ALNDs (n=56) with/without SLNB limits the ability to evaluate for 
complications with the higher risk group (i.e. ALND and those with lymphedema in each group).  
While ethnicity was not reported in the initial publication by Connor et al. (2013) the lack of 
diversity in clinical trials is often a limitation at this Midwestern Cancer Center.  The domains 
within the modified health-related quality of life model could not be fully evaluated due to 
limitations in the data collected and recorded in the database.  Many of the suspected risk factors, 
individual and environment characteristics such as income, education, social support, number 
lymph nodes removed, and complications with wound healing were not collected on case report 
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forms. Because some of the environmental characteristics are modifiable or may influence 
overall quality of life they are important to collect in future studies. 
 While quality of life scores were typically more favorable in women who did not have 
lymphedema, a statistically significant difference in quality of life scores was not always 
detected.  This finding was similar in women undergoin  ALND who had lower quality of life 
scores but likely due to the smaller sample size in this group a statistically significant difference 
was not identified.  Researchers (Belmonte et al., 2012) conclude that a disease specific 
questionnaire may be better at identifying clinically relevant differences between treatment 
groups and time points in breast cancer than the SF-36 physical functioning scale focused on 
lower extremity mobility.  Another limitation is that the participant’s history of radiation therapy 
was excluded from the analysis for parsimony and small sample size.  Lymph node status was 
not a part of the surgery axillary reverse mapping assessment form and also excluded for the 
same reasons.  
Recommendations for Future Research 
Future research needs to be conducted to explore the quality of life in breast cancer 
survivors as axillary surgery techniques advance. Th  study needs replication in women 
undergoing axillary reverse mapping procedures withSLNB and ALND with or without SLNB 
as the feasibility of this procedure evolves. The addition of a tumor site-specific tool such as 
FACT-B-4 to that assesses upper arm impairment may be useful in detecting relevant clinical 
differences (Belmonte et al., 2012).  Studies are needed specifically in those individuals 
experiencing lymphedema to gain additional knowledge of their quality of life challenges. 
Controlling for environmental and individual characteristics is recommended in future studies. 
Findings from Table 7 suggest that lymphedema in African Americans is more than twice that in 
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the Caucasian women at six months, one year and two years. Future studies need to target 
African American  women and other races to broaden th  knowledge base for complications. 
Inclusion of hormonal therapy as a biological function measure in is recommended in future 
studies.  While data collection is planned for three y ars post-surgery for this study only two 
years of data were analyzed.  With the increasing number of breast cancer survivors living longer 
lives there is ongoing need to study and manage quality of life issues beyond five years post 
diagnosis and treatment.  
Conclusion 
In summary, there was no significant difference in physical functioning for women 
receiving chemotherapy or no chemotherapy in a betwe n group or within group (time) analysis. 
Physical functioning was significantly higher at baseline compared to six months in the ALND 
group. There was no significant difference in functional status between surgical groups.  
Incidence of lymphedema in women undergoing the axillary reverse mapping procedure in the 
SLNB group diminished over time and increased over time in the ALND group.  At one year 
women with no lymphedema demonstrated significantly higher mental component summary 
scores compared to those with lymphedema.  At two years women with no lymphedema had a 
significantly higher physical component summary score compared to those without lymphedema.  
As much as 31% of the variance in general health was explained by seven variables (age, body 
mass index, surgery, pain, lymphedema, physical functio ing, and strength) with physical 
functioning and pain contributing the most.  Up to 37% of variance in mental component 
summary was explained by the same seven variables with physical functioning and pain 
contributing the most.  Only 19% of the physical component summary variance was explained 
by five variables (age, body mass index, surgery, lymphedema, and muscle strength) with body 
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mass index and muscle strength contributing the most. Quality of life benefits for SLNB are not 
clearly demonstrated. Based on this study they seem to become more apparent at two years. 
Further studies of quality of life issues beyond two years and in a larger more diverse 
heterogeneous population are recommended.   
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Appendix B 
 
Axillary Reverse Mapping Procedure Flow Chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inject radioactive isotope and 
scan for sentinel lymph node 
(SLN) using gamma probe 
Pre-incision: SLN is 
identified 
Inject blue dye into 
patient’s arm 
Complete procedure 
(sentinel lymph node 
biopsy and/or axillary 
lymph node dissection) 
 
 
Pre-incision: SLN is not 
identified (No 
localization) 
Inject blue dye into 
breast (nothing in arm) 
No localization: Inject blue 
dye into arm and preform 
ALND 
Localization: 
Complete procedure 
(SLNB and/or 
ALND) 
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Appendix C 
 
Lymphedema Assessment Axillary Reverse Mapping Case Report Form 
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Appendix C 
 
 
Lymphedema Assessment Axillary Reverse Mapping Case Report Form (continued) 
 
 
 
 
 
 
